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Abstract
Deep vein thrombosis (DVT) is a life threatening condition which is on the rise in the west-
ern world [1] yet the mechanisms behind DVT remain unknown. Using microfluidics and
simulations it is possible to determine the physical mechanisms that could be the cause of
DVT. By mimicking the murine model (stenosis model) it was possible to see if the amount of
stenosis and presence of side branches influenced flow. I was determined that the influence
of a restriction did not alterr the flow enough to encourage thrombus formation, however
the stenosis would increase the number of cell-cell collisions which could be the reason for
a thrombus occurring in vivo. Finite element modelling was also used to surpass the limita-
tions of the experiment, resulting in a the same conclusions. A major limitation of the murine
model is that it ignores the possibility of a bypass of the stenosed region, leading to the sec-
ond model.The bypass model was used to determine which set of parameters are important
to encouraging a bypass: position of side branch, width of side branch channel and the size
of stenosis. Finally, a third model was also developed, the valve model to explore how flow is
influenced by flexible valves. The valves are fabricated with varying stiffness to better under-
stand how the stiffness of valves can influence flow through a vein inducing pro-thrombotic
conditions. This model is more relevant for larger mammals. Three models of biology have
been implemented to demonstrate DVT can be instigated by physical parameters and these
fundamental conditions are not to be dismissed.
ACKNOWLEDGEMENTS
Throughout my PhD I have had the pleasure to work alongside some outstanding researcher’s
and staff. Firstly I would like to thank the outstanding supervision of Dr. Daniele Vigolo, who
has supported, guided and advised me through every aspect of my PhD and career choices. I
could not ask for a better primary supervisor, his patience and encouragement has undoubt-
edly inspired me for my future career in academia. I would also like to thank my secondary
supervisors: Dr. Alessio Alexiadis for his patience with computational aspects of my work
as well as providing me with teaching opportunities within his module. Dr. Alexander Brill
for his enthusiasm towards the project and constant drive towards publications and future
experiments. And finally, Professor Gerard Nash, as without his experience and knowledge
of academia would not have been able to rationalise expectations of the project. Collectively,
my supervisors helped to keep my motivation and enthusiasm for the project.
My research would have not have been possible without the support of my friends, in-
cluding the routine enforced by Twelve O’ Clock Lunch Crew in my final year. I would also
like to acknowledge Meg Cooke, Kamlesh Patel and Daniel Lighter, the writing and pizza
nights, the late nights in the office in final year and the stressing in unison reminded me I
was not alone in this journey. I would also like to acknowledge Birmingham Moseley Wom-
ens Rugby team as it is not only friends made in academia that provide support and encour-
agement.
Finally I would like to thank my partner Richard Kidson and Family both of which have
been equally there in moments of need. My PhD has been a roller-coaster of emotion and




1.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Current in vivo Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.2.1 Murine Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2.2 Large Mammal Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.3 In Vitro Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.3.1 Microfluidics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.3.2 Evaluation of Flow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.4 Computational Fluid Dynamics . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.4.1 Mesh Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.4.2 Mesh Free Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2 Materials and Methods 29
2.1 Geometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.1.1 Stenosis Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.1.2 Bypass Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.1.3 Valve Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.1.4 Simulation Geometries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.2 Fabrication of the Device . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.1 Main Channel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2.2 Data collection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.2.3 Flow Visualisation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3 Stenosis Model 58
3.1 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.1.1 Optimisation of GPV set up . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.1.2 Flow through Symmetrical Channel . . . . . . . . . . . . . . . . . . . . . . 62
3.1.3 Flow with the presence of a Closed Side Branch . . . . . . . . . . . . . . . 65
3.1.4 Flow with the presence of a Side Branch . . . . . . . . . . . . . . . . . . . 66
3.1.5 3D Cylindrical Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.1.6 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
4 Bypass Model 78
4.1 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.1.1 Influence of Position of Side Branch . . . . . . . . . . . . . . . . . . . . . . 80
4.1.2 Influence of Side Branch Width . . . . . . . . . . . . . . . . . . . . . . . . . 85
4.1.3 Influence of Degree of Stenosis . . . . . . . . . . . . . . . . . . . . . . . . . 87
5 Valve model 96
5.1 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
5.1.1 Successful fabrication of flexible Valves . . . . . . . . . . . . . . . . . . . . 96
5.2 Characterisation of Valve Stiffness . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
5.2.1 Varying concentration of Photo-initiator . . . . . . . . . . . . . . . . . . . 99
5.2.2 Varying exposure time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
5.2.3 Varying concentration of PEGDA . . . . . . . . . . . . . . . . . . . . . . . . 102
5.2.4 Young Modulus Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
5.3 Flow Patterns Around the Valves . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
5.3.1 Particle Accumulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
5.4 3D Printed Valve Geometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
5.5 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
6 Conclusion and Future Work 125
6.1 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
6.1.1 Stenosis Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
6.1.2 Bypass Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
6.1.3 Valve Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
6.1.4 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
6.2 Limitations and Future Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
6.2.1 Stenosis Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
6.2.2 Bypass Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
6.2.3 Valve Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
6.2.4 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
List of References 134
A Appendix 150
A.1 Chapter 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
A.2 Chapter 3: Stenosis Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
A.3 Chapter 4: Bypass Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
A.4 Chapter 5: Valve Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
LIST OF FIGURES
1.1 A schematic of the cardiovascular system and vessel physiology. Adapted from
[2] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 A schematic of how the muscle contraction pump works. One valve opens as
the one behind closes to prevent back flow. Not to scale . . . . . . . . . . . . . . 4
1.3 A diagram illustrating Virchow’s Triad . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.4 Schematic images indicating the differences between A) a full ligation, B) a
stenosis as well as showing the presence of C) side branches highlighted in blue
and D) back branches in dark red. . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.5 A schematic diagram illustrating the difference between positive and negative
photoresists used in photo-lithography . . . . . . . . . . . . . . . . . . . . . . . . 14
1.6 An example of the imaging process carried out for DDM. Starting with a) the
static contribution, b) speckle enhancement image when the static contribu-
tion is subtracted from one of the 1000 frames at 10 ms and finally c) for frames
which are 200 ms apart [3] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.7 A visual representation of elements, nodes and boundaries typically used in
FEM simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
1.8 A mesh representation showing the differences between a conforming mesh
approach (a) and a non-conforming mesh approach (b). Figure taken from
Ariane et al 2017 [4] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
1.9 A figure showing different algorithms used to investigate clot formation. A)
Uses a ’calcification’ approach, B) is a free clot and C) is a ’filiform clot’ Figure
taken from [4] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.1 A diagram illustrating the different stenosis, closed side branch geometries and
side branch geometries at the different positions. . . . . . . . . . . . . . . . . . . 30
2.2 A 3D CAD drawing of the cylindrical device at different angles A) is the top view
and B) illustrates the end of the channel where R = 0.5 mm and C) the stenosed
region r = 0.15 mm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.3 An example of a CAD drawing of the bypass geometry with the three different
positions of the 100 µm side branch, black = 300 µm, red = 600 µm and green =
1600 µm away from the stenosis. Regions are labelled and L = 2.12 cm . . . . . . 31
2.4 The CAD image of the pump devices, the A) showing a curved design, B) the
short based pump (Lp = 500 µm) and the C) a long based pump (Lp = 800 µm)
geometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.5 The CAD image of the geometries that were tested to secure the valves in place 33
2.6 The CAD images of the valve geometries used for in situ material characterisa-
tion (straight valve) and flow studies (leaflet valve) . . . . . . . . . . . . . . . . . 34
2.7 The 3D CAD drawing of the static valve structures which were printed on the
3D printer. L = 12 mm, H = 2 mm, W = 4 mm, w= 0.5 mm vB = 1 mm . . . . . . . 35
2.8 A Is the geometry with the valve geometry taken from the mask with A1 and
A2 showing the points which have been added for mesh refinement. B is the
curved valve and C is the geometry for the short thick valves . . . . . . . . . . . 36
2.9 A flow diagram of the photolithography process carried out in the clean room . 38
2.10 A not to scale picture showing the Form 2 3D laser printer used for the fabrica-
tion of the cylindrical devices, along with geometry orientation on the printing
place A) without a base and B) with a base. The printing direction is a raster
along the x, y plane. D = 1 mm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.11 A schematic diagram illustrating the method behind the in situ fabrication of
flexible PEGDA valves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.12 A 3D (A) and 2D (B) diagram illustrating the parameters used in equation 2.1. . 43
2.13 A schematic diagram demonstrating the experimental set up including syringe
pump to control flow rates, microfluidic device and waste collection. Although
fluid here is illustrated with blue, in actual experimental set up appear to be
white PS particles due to the scattering of light off the nanoparticles making
the solution translucent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.14 A microscope image of demonstrating the pump channels filled with ink. Scale
bar = 75 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.15 Flow diagram showing the image processing carried out using imageJ for GPV[5] 48
2.16 A visual of the standard procedure carried out using PIVlab. A) indicates where
the ROI can be set and B) where the mask can be set. This can be drawn man-
ually or imported. C) Is where it is possible to set the area at which an average
of vectors can be considered. With this example a small area can be used as
the GPV is of a high quality. After the analysis has occurred and vectors have
been computed. Post processing can occur. Firstly, D) the calibration of the
velocity to operate in m/s compared to pixels per second along with the setting
the reference distance. Finally E) vector validation to remove anomalies . . . . 49
2.17 Figure showing the standard mesh used for the 2D simulations, there is slight
refinement around the stenosis to account for faster velocities . . . . . . . . . . 54
2.18 Images showing the different mesh refinements for each geometry. A and B
show the valve which is taken from the CAD file for the photo-masks, C shows
the mesh partitions for the vavles and the fluid and D and E show the short
thick valves to look at an extreme geometrical change on the fluid flow . . . . . 56
3.1 A graph showing that the flow is in steady state within the 100 frames recorded.
This particular graph is for flow rate 20 µL/min and a fps of 20 000. Scale bar =
40 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.2 This is a graph to show the reliability of the GPV set up including: syringe pump
and image capture. The theoretical velocity through a W = 200µm channel
is displayed by a red dashed line and the orange dashed line is the stenosed
region of 80 % with a w = 40µm. The experimental result is presented by the
circular data points. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.3 A velocity magnitude map of the 200µm microfluidic channel with 80 % steno-
sis. The flow rate here is 20 µL/min and the capture rate is 20 000 fps with 50
µsec shutter speed. The markers seen on this velocity plot are to determine the
steady state of flow over a 100 frames and the results can be seen in figure 3.1.
Scale bar = 40 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.4 A velocity magnitude map of the 500µm microfluidic channel with 80 % steno-
sis. The flow rate here is 40 µL/min and the capture rate is 10 000 fps with 50
µsec shutter speed. Scale bar = 250 µm . . . . . . . . . . . . . . . . . . . . . . . . 66
3.5 A velocity magnitude map of the 500µm microfluidic channel with 80 % steno-
sis. The flow rates in the side branch and main channel are equal of 100µL/min.
Scale bar = 250 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.6 Bright-field microscopy images of blood flow through the 200 µm microfluidic
channel with 70 % stenosis with side branch positioned 600 µm away from the
stenosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.7 A CAD image showing final geometry for the 3D printed stenosis device high-
lighting a particular region of interest for the investigation of flow around the
stenosed region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.8 The velocity profiles of the z plane for the cylindrical device. The positions A-I
are highlighted above the graphs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.9 A is the simulation result calculated using COMSOL compared with B which
is the experimental result of the closed side branch 500 µm channel with 80%
stenosis. Scale bar A = 500 µm. Scale bar B = 250 µm . . . . . . . . . . . . . . . . 73
3.10 This was the first converging result using Elmer FEM software. Firstly A shows
the mesh created in gmsh followed by the convergence history in plot which
took 8.39 seconds B) and C) is the velocity profile result presented using ParaView 75
3.11 The velocity magnitude profiles of the cylindrical device with inlet velocity set
to 0.13 m/s (near the maximum seen in microfluidic devices previously). The
plot indicates the strong parabolic flow through the D=300 µm stenosis of the
full cylindrical device. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
4.1 A CAD drawing of the bypass geometry with the three different positions of the
W = 100 µm side branch. Blue arrows indicate flow from the syringe pumps . . 80
4.2 Four graphs demonstrating how the difference in side branch position directs
flow through the bypass geometry. Regions highlighted about the graphs are
selected and the mean velocity has been plotted. A and B shows the velocities
in the different regions when the side branch flow rate is changed from 1-10
µL/min (x axis) and the main channel flow rate is set to 10 µL/min. C and D
show the alternate condition, the main channel changes flow rate from 1-10
µL/min and the side branch flow rate is maintained at 10 µL/min. A and C
are plots for side branch positioned 600 µm away from the stenosis and plots
B and D show velocity plots for side branch positioned 300 µm away from the
stenosis. Both side branches have a WSB = 200µm. . . . . . . . . . . . . . . . . . 82
4.3 Velocity magnitude map of bypass design, positioned 1600 µm away from the
stenosis with WSB = 100µL/mi n . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4.4 Data showing how the width of the side branch means that there is a stagnant
region up until 9 µL/min. Degree of stenosis = 80 %, width of channel = 100 µm
position C. Red arrows indicates the direction of flow. . . . . . . . . . . . . . . . 86
4.5 Data showing the how the velocity in the four regions changes as the side branch
is kept at 10 µL/min and main channel increases, as seen by the red line. The
width of the side branch is 100 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.6 The CAD drawing of the devices used to apply a controlled stenosis in the main
channel. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.7 Plots for 50% stenosis and 100µm side branch. A) plots the velocity for increas-
ing side branch flow rate, and B) is for increasing main channel flow rate . . . . 90
4.8 An indication of how the velocity was measured using GPV, with A) showing the
bright field image of the device including the pump mechanisms, B) the GPV
indicating the lack of signal within the pump systems and finally C) showing
the velocity magnitude through the main channel and side branch. . . . . . . . 92
4.9 Linear correlation between increased pressure in the pump system and the de-
gree of stenosis. Degree of stenosis is the percentage at change between the
straight channel (300 µ) and the restriction induced by the external pumps. Er-
ror bars are the mean standard deviation of three different experiments using
the pumps to restrict the channel. R2 value = 0.95. . . . . . . . . . . . . . . . . . 93
4.10 Three images indicating that even with 50 % stenosis no bypass occurs. . . . . . 94
5.1 A simple schematic illustrating how the deflection was measured in the simple
valves. The red arrows represent flow. . . . . . . . . . . . . . . . . . . . . . . . . . 99
5.2 A graph to present how the concentration of PI alters the amount of deflection
depending on concentration of PI. The lines are fitted via the following equa-
tion f (x) = a ∗xb + c. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
5.3 A bright field image of the simple valve with the ’skirt’ highlighted in pink re-
ducing with shorter exposure times. . . . . . . . . . . . . . . . . . . . . . . . . . 101
5.4 A graph showing how exposure time influences the degree of deflection within
the microfluidic device. Red points are for 300 ms exposure and blue is for 325
ms exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
5.5 Both graphs show the deflection in response to flow rate with different concen-
trations of PEGDA. A) is the deflection for 8 % PI and B) is the defection for 4 %
PI. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
5.6 The above figure represents data collected from 8% v/v PI A) shows a typical
graph of deflection against volumetric flow rate with B) highlighting the linear
region, small deflection region used for the calculation of E shown in graph C).
The green data point represents the maximum E for PEGDA 575 . . . . . . . . . 105
5.7 Velocity profile maps showing the difference in flow fields around the valves.
No masking was used, yet valves are still visible as no flow regions. Straight
valve scale bar = 150 µm (top three images) and the leaflet valve scale bar = 75
µm (bottom three images). Re = 2, 3, 5 respectively. . . . . . . . . . . . . . . . . . 108
5.8 A velocity map and streamlines highlighting how as Re increases the size of
the vortex also increases. The valve properties are 2 % w/v [PI] and 40 % w/v
[PEGDA]). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
5.9 A representation of how vortex area increases with Re. Points are natural log
(ln) of both Vortex area and Re number. R2 = 0.99. f (x) =−12.61∗x−2.45 +10.95. 110
5.10 Following on from graph 5.9 this plot adds a third dimension to the data in-
dicating the relationship between Re, vortex area and the tangent velocity is
linear. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
5.11 A graph to present how the amount of deflection influences the size of the vor-
tex at different velocities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
5.12 A schematic of the PS particle along with the PEGDA molecule. . . . . . . . . . . 113
5.13 A bright field microscopy image of the 200 nm particle accumulation on the
valve tips. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
5.14 A histogram plot showing how the stiffness of the valve encourages particle
accumulation on the valve tips. T = time (min). . . . . . . . . . . . . . . . . . . . 115
5.15 Bright field images showing the particle build up over time in symmetrical (top)
and asymmetrical (bottom) stiffness of valves. The concentration of 10µm par-
ticles is 1 % w/v. The symmetrical valve has the composition of 4 % v/v PI and
50 % vv PEGDA. The asymmetric valve is the same composition as the sym-
metrical valves, however the exposure time for the left (most flexible) and right
(stiff) are different. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
5.16 A schematic representation of the 3D printed valve device highlighting the re-
gion of interest where the results at the bottom of the figure were obtained. . . 119
5.17 A zoomed in velocity magnitude map of featuring the long valves. . . . . . . . . 120
5.18 The velocity map above the graphs indicate the coordinates on position y in
which Plot A) shows the parabolic flow before the valve increasing as the ve-
locity increases. This is also highlighted in plot B), which is the velocity after
the valves, it indicates that there is a vortex at velocities 4 and 5 highlighted
by the black dashed circles. The Purple line in both plots is the parabolic flow
visualised in the previous figure 5.17. . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.19 Velocity magnitude map of the simulation data showing the presence of a vor-
tex and that it increases with Re number. . . . . . . . . . . . . . . . . . . . . . . . 122
5.20 A zoomed in velocity magnitude map of featuring the long curved tipped valves. 123
A.1 Comparison between the two positions B and C. Plots A and C show position
B side branch and main channel flow rates respectively and plot B and D show
position C side branch and main channel flow rates changing. . . . . . . . . . . 155
A.2 An example of the different velocities around the valve, indicating the stagnant
region behind the valve as well as the fast region through the centre. . . . . . . . 156
LIST OF TABLES
1.1 Typical diameter of in vivo veins and study . . . . . . . . . . . . . . . . . . . . . . 7
2.1 A table to present the scaling factors for designing the masks depending on
objective used . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.2 Necessary values to remain constant throughout all simulations . . . . . . . . . 51
2.3 A table to present number of numerical elements and nodes within each mesh
of the stenosis model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
2.4 A table to present number of numerical elements and nodes within each mesh
A-E, along with equations applied . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.1 A table presenting to performance of the CMOS cameras used for capturing GPV 59
3.2 A table to present proteins in blood plasma and their corresponding sizes . . . 62
5.1 Coefficients used in the power 2 fitting in 5.2 . . . . . . . . . . . . . . . . . . . . 100
5.2 Coefficients used in power 2 fitting for figure 5.4 . . . . . . . . . . . . . . . . . . . 102
5.3 Coefficients used in power 2 fitting for figure 5.5 . . . . . . . . . . . . . . . . . . . 104
5.4 Table displaying E for various concentrations of PI and PEGDA. The varying
colour of the E column symbolises maximum E (red) and minimum E (green) . 106
ABBREVIATIONS
BP - Bypass
CAD - Computer aided design
CCD - Charge coupled device
CFD - Computational fluid dynamics
CMOS - complimentary metal oxide semiconductor
D - Diameter
d - depth of valve (µm)
DDM - Differential dynamic microscopy
DLS - Dynamic light scattering
DMHS - Discrete multi-hybrid system
DVT - Deep vein thrombosis
E - Young’s Modulus
FE - Finite element
FEM - Finite element methods
GPV - Ghost particle velocimetry
H - Device width
IVC - Inferior vena cava
Lp - Length of pump geometry (Bypass Design)
MCB4 - Main channel before side branch
MC Aft SB - Main channel after side branch (but before stenosis)
MC AftSten - Main channel after stenosis
MRI - Magnetic resonance imaging
NAc - Numerical Aperture of the condenser lens
PDMS - poly(dimethylsiloxane)
PE - Pulmonary embolism
PEGDA - polyethylene glycol-diacrylate
PI - Photo initiator
PIV - Particle image velocimetry
PRP - platelet rich plasma
PS - Poly-styrene
rPSGL-Ig - recombinant P-selectin glycoprotein ligand Ig
PTV - Particle tracking velocimetry
RAM - Risk assessment models
R - Radius of cylinder design
r - Radius of stenosis of cylinder design
Re - Reynold number
ROI - Region of interest
SB - Side branch
T- Time
UV - Ultra-Violet
µPIV - micro particle image velocimetry
W - Device width (µm)
WSB - width of side branch




Deep vein Thrombosis (DVT) is a painful and dangerous condition where blood clots within
the deep veins (e.g. common femoral vein). The clots can become unstable and travel to
the lungs resulting in a life threatening condition called a pulmonary embolism (PE). DVT
and PE combined cause 25,000 deaths annually in the UK [6], yet the physical mechanisms
behind DVT remain unknown. This is due to the lack of in vitro research behind the phys-
ical parameters encouraging thrombus formation. It is believed that venous valves play a
fundamental role into the development of a thrombus either: behind the valve flaps or on
the leaflet itself. However, it is has not been determined where or how a thrombus is initi-
ated within the deep veins. Using fundamental fluid dynamics used daily in engineering it
is possible to investigate various possibilities into how DVT occurs and grows within a ve-
nous system. In industry, fluid dynamics is rudimental for the designing, understanding and
the running of many chemical plants from: cosmetic, pharmaceutical, house hold and oil to
name a few. From the initial designing of a chemical plant, it is first considered how fluid will
be transported around the plant from reagents to packaging.
The physiology of the cardiovascular system can be considered as a complex network
of pipelines with varying diameters and two pumping systems: the cardiac pump (heart)
for arterial flow and the skeletal muscle pumps for venous flow. Thinking from a physical
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science perspective, and stripping away biology it is possible to model and understand com-
plex flow patterns within the venous system. Engineers have to consider many parameters
of fluid properties: the viscosity, Newtonian/non-Newtonian characteristics, composition,
temperature dependencies [7] to plant design: the diameter and roughness of the piping,
positioning of pumps and valves [7]. All of these factors contribute to the smooth transporta-
tion of fluid around the plant and aim to reduce blockages forming. It is also a lot easier to
make minor alteration to the pipework to improve efficiency of the plant, both of which are
not possible in nature. However, it is possible to use the theories and technology intended
for physical sciences and apply them to a biological problem. Throughout this thesis it shall
be explained how physical sciences can be used to highlight potential pro-thrombotic con-
ditions in DVT.
Currently there is plentiful research into arterial and heart related cardiovascular diseases
yet the venous system is under appreciated. It is only until recently that DVT has become a
topical research focus for the NHS. The main risk factors are: old age, immobility (bed ridden
after surgery, long haul flights, etc) and pregnancy. Obviously, all risk factors are increased
when combined with old age. There is a dramatic, increased risk of DVT in patients over
the age of 50 increasing from 1-3 individuals per 1000 to 1 in 100 annually in the United
States[8]. Current methods for determining the prognosis of DVT is a risk assessment model
(RAM) scoring approach [9]. This technique relies on electronic records being up to date to
develop a data base to aid diagnosis as well as predicting the likelihood of developing DVT.
However, these systems are less than accurate and there is vast room for improvement. In an
attempt to improve the scoring systems D-dimer and p-selectin bio-markers were added in
order to assess the risk of developing DVT [9]. However, in order to progress the scoring sys-
tem further it would be useful to understand how geometry of veins and valves influence clot
formation. It is hypothesised that there is a link between venous geometry and flow charac-
teristics correlating to thrombus formation[10]. Despite the increase in identification and
treatment of DVT the number of people developing this disease is increasing annually in the
western population[11]. Current systems are not sufficient enough for initial diagnosis, as
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the criteria is far too vague. This means there needs to be a better, non-invasive alternative.
This can be carried out by determining biophysical predictors which can be visualised using
ultrasound doppler techniques [12].
The cardiovascular system is a complex network of blood vessels (figure 1.1 A). The phys-
iological differences between the vessels is to ensure the efficiency of blood flow around the
body (figure1.1 B). Typical diameters,D, of veins and arteries depend on where in the body





Figure 1.1: A schematic of the cardiovascular system and vessel physiology. Adapted from [2]
Arterial flow is pumped by the cardiac muscle (heart) around the body at high pressure
(represented in red in figure 1.1), in order to withstand this pressure the arteries have a thick
layer of smooth muscle compared to veins [13] which maintains the shape of the artery. The
increased rigidity of the arteries also helps maintain the pressure of the blood ensuring it
reaches the capillaries. The capillaries have a significantly reduced vessel diameter. The de-
crease in diameter results in a pressure drop after the capillaries [14]. The capillaries are at
the end of the arterial network and therefore the pressure exerted at the beginning by the
heart has now been exhausted by the time it reaches veins. The capillaries have a vessel wall
that is only one endothelial cell thick, meaning they cannot withstand high pressures with-
out rupturing. The endothelial cells enable the transfer of oxygen to surrounding tissues,
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and the removal of carbon dioxide created in aerobic respiration [14]. As the blood is now
at a significantly reduced pressure, the veins have to be specialised to enable the return of
blood back to heart. Venous blood vessels only have a small layer of smooth muscle (figure
1.1) making the walls very flexible, this is beneficial as venous flow is dependent on the con-
traction of surrounding muscles (figure 1.2). Another feature present in veins is valves, the
valves prevent back flow of blood and open and close in an alternate fashion (i.e. one valve
opens as the previous one closes), figure 1.2.
Figure 1.2: A schematic of how the muscle contraction pump works. One valve opens as the
one behind closes to prevent back flow. Not to scale
The physiological differences between arterial and venous blood vessels are important
factors to consider when trying to understand mechanisms behind thrombosis. It can be
assumed that in vitro models to represent arterial thrombosis are not relevant when try-
ing to understand venous thrombus formation. Further evidence supporting the assump-
tion that there are two mechanisms behind thrombus formation for arteries and veins. The
differing in mechanisms behind thrombosis alter the composition of the thrombus. Blood
clots contain a mixture of platelets, fibrin and red blood cells [8]. Importantly, the combina-
tion of these cells/proteins highly depend on where the blood clots are formed under spe-
cific conditions. Arterial thrombus formation occurs under high wall shear stress conditions
(20−30N /cm2) [15], and is usually a result of damage to the vessel wall or after an atherscle-
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rotic plaque. They are platelet rich and generally treated with an anti-platelet drug [8]. This
is different to thrombus formation within the veins, as thrombus formation occurs at lower
shear stress condition (1−2N /cm2) and is generally fibrin rich and containing majority red
blood cells with a platelet head and is therefore treated with anticoagulants [8].
In 1884 Virchow proposed a triad of conditions which would increase the likelihood of
thrombus formation (see figure 1.3) [11]. It became the fundamental understanding behind
thrombosis progressing advancing research for over 20 years triggering research into looking
at vessel damage [16, 17, 18, 19], activation of platelets, [20, 21, 22, 23] and stasis [24, 25, 26].
Figure 1.3: A diagram illustrating Virchow’s Triad
However, thrombosis within veins is not a result of vessel damage as it is not under high
pressure. Primarily DVT is caused by stasis and hyper-coagulability as mentioned previously.
Once a person is diagnosed with DVT, they are at a higher risk of developing DVT again in-
dicating that it is a geometrical influence on flow that promotes thrombus formation [11].
There could also be physiological differences that develop with age. It has been said that
the older population have an increased reactivity of platelets [27]. The reason for the in-
creased reactivity is unknown, and could be a result of many physical factors: stiffening of
blood vessels, change in blood rheology or stiffening of venous valves. All of which will re-
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sult in changes to the flow patterns within veins, changing flow conditions around the ve-
nous valve. A change in flow pattern could be a larger stagnant region behind the valve, in
the valve sinus. This large area of stasis would encourage clot formation because blood is
a non-Newtonian fluid, meaning when blood is stagnant it will thicken and eventually clot.
Valve stiffness has been investigated for cardiac flow [28] and even more recently for venous
valves [29]. Both indicate that valve stiffness increases with age. Another suggestion could
be that with the increased stiffness of the blood vessels, degradation of muscle tissue in the
lower extremities could reduce the amount of blood flow through the deep veins and result
in pooling behind the valve pocket.
1.2 Current in vivo Models
Research into mechanisms behind DVT is limited to physical and chemical interventions to






































































































































































































































































































































































































































































































































































































































































The most established model for investigating DVT is the murine model as it is the most sim-
ple, reproducible, controllable in vivo methodology [44]. However mice are not susceptible
to thrombus formation, meaning that they have to be genetically modified to induce throm-
bosis. Genetic modification can also be advantageous as it enables research in t the identifi-
cation of biomarkers. Usually these studies are compared to a wild type mouse [45, 46, 47].
The studies have been beneficial for highlighting specific genes and bio-molecules that are
important to the development of DVT. The methodology is well established and originally
involved the full ligation of the inferior vena cava, IVC (see figure 1.4 A). This will stop blood
flow completely through the IVC and therefore result in the formation of a thrombus. Further
development of this model has involved the partial restriction of the IVC, known as a steno-
sis as seen in figure 1.4 B. The IVC is a popular choice as it is the largest vein in a mouse [44].
The full ligation of the IVC ensured the reproducibility of thrombus size and weight, allowing
for specific investigation of biochemical markers of DVT [45, 48, 49], however this is not true
for the stenosis model [33]. The reason for this is that the needle used to apply the stenosis
may not be blunted which could cause injury to the vessel wall [44]. Yet both have been pi-
oneering for understanding the chemistry behind thrombus formation and have aided drug
development.
The murine model has briefly looked at geometric influences on thrombus formation.
One particular study investigates the presence of back branches and side branches on the
size of thrombus. J. Diaz et al found that thrombus formation was reduced when back
branches were not ligated [33]. It is hypothesised from this study that the back/side branches
are important to thrombus formation and that their presence disrupts flow within the IVC
[33]. It was also found that when the IVC is stenosed, and all back/side branches are closed,
the thrombus formed weighs more (≈32 mg) than in conditions where only the back or side
branches are closed (not both) [33]. This is interesting as it suggests that again flow will not
only determine whether a thrombus will form but also how big the thrombus will become
with in the same time scale. Since the study carried out by J. Diaz et al there has been no
8
Figure 1.4: Schematic images indicating the differences between A) a full ligation, B) a steno-
sis as well as showing the presence of C) side branches highlighted in blue and D) back
branches in dark red.
further investigation into the influence of side branches and its effect on thrombosis. There-
fore, within this thesis, this will be starting point for investigating DVT as the presence of side
and back branches may not disrupt flow, but could be providing a bypass route back to the
heart. In the stasis models (full ligation of the IVC) the mouse is alive while the thrombus
forms suggesting there is an alternative route back to the heart.
The murine model dominates research into DVT due to its technical simplicity and re-
producibility [31]. Unfortunately it is unable to determine the physical predictors due to the
complication of in vivo imaging of blood flow. A thrombus can be detected as early as 3 hrs
after the surgical procedure, however typically thrombi are measured after 48 hrs [44]. This
large time gap between when they can detect a thrombus to when they are typically mea-
sured suggests there is limited understanding behind how a thrombus is initiated and the
growth rate. Imaging blood flow in vivo is a major hindrance of understanding the physi-
cal mechanisms behind DVT. As mentioned previously blood does not exhibit optical trans-
parency, therefore fluorescently labelled platelets are required to track the velocity through
the vein. A popular approach for measuring DVT is intravital microscopy [50]. Usually intrav-
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ital microscope uses confocal microscopy allowing for 3D imaging of the blood flow through
the vein, however, within these studies it is not stated which plane the flow of platelets is be-
ing investigated. This means the platelets can be at the vessel wall, where the velocity is slow,
or in the centre, where the velocity would be at its highest. Therefore the ability to compare
findings between these studies is relatively restricted. Intravital microscopy allows for the
investigation of blood flow in vivo whilst the animal is still alive [51]. In the case of inves-
tigating blood flow in the murine model, platelets are generally fluorescently labelled [45].
An interesting study implemented intravital microscopy to investigate the growth and com-
position of thrombus formation in mice. To induce thrombus formation ferric chloride was
used to induce injury to the vascular wall of the venules [52]. It was found that thrombus
formation occurred in a matter of minutes, differently to what has been reported in other
studies where hours have been waited before thrombus composition has been studied.
To reiterate, a major drawback to the IVC stenosis model is the inability to reproduce
thrombus size and weight for accurate pharmaceutical studies [53]. It would be ideal for
thrombus formation and growth to be predictable and therefore more work needs to be car-
ried out to determine the mechanisms behind DVT. Throughout the majority of the stenosis
models there is a lack of consideration for the possibility of a bypass. Yet it is reported that
even if there is full ligation of the IVC in a mouse it will behave normally, and not be impaired
with the stopped blood flow through a major vein for at least a day [44]. Mice are obviously
physiologically and genetically different to humans meaning that the mechanisms behind
thrombosis will be different [54]. Another important factor is that the IVC runs horizontally
along the mouse to the heart and therefore will lack gravitational effects which would be
possible in larger animals and humans. It has not yet been reported whether or not mice
have valves within their venous network, yet it is believed they play an important role in DVT
in humans. For this reason, more research needs to be carried out investigating blood flow
around valves in order to understand how and where thrombosis occurs within the venous
network.
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1.2.2 Large Mammal Models
The use of larger animals ensures a better representation of humans for pharmaceutical de-
velopment and investigation into mechanisms behind DVT. It was found that with a greater
stenosis (80-90%) there is an increased probability of the occurrence of a thrombus in pig
models [10]. The time scale for these experiments varied from 2 hours to 5 days depending
on the intervention inducing thrombus [10].
It is thought that most venous thrombi originate in the valve pockets as a result of low
oxygen tension, and they develop over a period of hours – days [44]. The large variability
in time scales indicates no one truly knows how DVT is initiated or propagates. In order to
study thrombus formation which are more physiologically relevant to the human disease,
DVT, larger mammals need to be investigated [55]. Larger mammals generally have valves in
order to get the blood back to the heart and prevent back flow. There is not yet an in vitro
model allowing for this investigation.
The canine model mentioned in table 1.1 temporarily stops blood flow through a 3 cm
section of the right jugular vein, however there is no mention of the vein reaching normal
diameter after the clamps are removed [38]. Although the dogs were treated with sodium
morrhuate which is a drug diagnosed to help with vein dilation, there is no report on how
each dog is affected [38]. This could be the reasons for why there appears to be no clear
correlation between thrombus weight and age. The data is complimentary to other findings
in that there is obviously geometry influences the size and weight of the thrombus over time
as this is missing in their comparative study and the results focus on how large deviations
occur depending on human interpretation, weight and age of the thrombus and weight of
the dog [38].
The same can be said for the study carried out on baboons which, similarly to the murine
model, had thrombosis induced by blocking their renal IVC for 6 hrs [41]. The main focus of
this study was to understand the role of P-selectin in thrombus formation. In order to do this,
8 of 12 baboons were injected with recombinant P-selectin glycoprotein ligand Ig (rPSGL-Ig)
which has a high affinity to P-selectin, thus reducing the effect of P-selectin [41, 18]. However,
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it fails to report if there is a difference in IVC diameter, and although this may have been
disregarded as irrelevant due to the promising and consistent results from the mouse model,
it could have been an obvious reason to why there were inconsistent results within this study.
Albeit, the baboons underwent full occlusion of the IVC for 6 hrs, which is not representative
of how thrombosis occurs. Therefore, a further study could investigate a partial stenosis
to emulate a constricted vein and the effectiveness of rPSGL-Ig in correlation with vessel
diameter and degree of constriction.
A blatant observation from table 1.1 is the lack of information regarding vessel diameter
and presence of valves. The majority of in vivo research seems to disregard the possibility
that vein diameter and venous valves are an important factor when looking into thrombus
formation and yet it is a fundamental physiology for the efficient, continuous blood flow
around the body; human, non-human, small and large animals. This can be standardised
and controlled using an in vitro approach. In addition, another limitation to current in vivo
models is that in order to induce thrombus formation there has to be a physical (stenosis),
chemical or genetic intervention [31]. The stenosis model in particular induces thrombus
formation by forming a ’bottle neck’ increasing the cell-cell interaction and therefore en-
couraging the initiation of thrombosis.
As hinted at previously, within the murine model the animals have a fully ligated IVC
which is the largest vein within a mouse yet they survive for many hours [53]. Even in the
stenosis model where the thrombus fully blocks the IVC the mouse is only euthanised 48
hours after the stenosis [45]. The mice remain alive and although their activity is not re-
ported it are presumed unaffected by the blockage otherwise the time before euthanasia
would be brought forward. This indicates that there must be an alternative route back to
the heart bypassing the obstruction. The idea of a bypass has been underestimated when
it comes to using the murine model to understand physical mechanisms behind thrombo-
sis. It was reported that the presence of side branches and back branches reduced the size
and probability of developing a thrombus due to recirculation around the stenosed region
[53]. Although this is very unlikely to be true due to the size and properties of blood within a
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mouse being laminar (discussed in greater detail in sections 1.3.1 and chapter 3).
Unfortunately the presence of a bypass in humans may not be as obvious, although blood
does make its way back to the heart. When a patient has been diagnosed with DVT one of
the symptoms is swelling and pain of the limb. This swelling is due to a build up in pressure
within the smaller veins and capillaries causing severe pain. The pressure build up could be
caused by ageing veins having a decreased elastic tissue. A decrease in elastic tissue would
mean that the veins are more prone to compression [58, 59], inducing a similar effect to
a stenosis (figure 1.4). This could also explain how immobility is a risk factor for DVT with
prolonged stenosis of a major vein blood may flow similarly to that seen in the murine model
making it a good starting point.
1.3 In Vitro Approach
1.3.1 Microfluidics
Microfluidics is a field which has been developing rapidly over the last 20 years [60, 61].
Generally it is a small channel on a micro-scale which exhibits unique fluid properties. Mi-
crofluidic fabrication methods hit a major breakthrough when Whitesides et al developed
poly(dimethylsiloxane) (PDMS)device fabrication; increasing speed and ease of making mi-
crofluidic chips [62]. It is possible to design complex geometries using computer aided de-
sign (CAD) and fabricate using photo-lithography achieving a feature size of 1 µm depend-
ing on the resolution of the photo-mask. Photo-lithography is a well established micro-
fabrication technique using UV curable photo-resists. Using a mask aligner uniform UV light
is projected through a mask curing the resist in the desired geometries (see methods section
2.2.1). There are different photo-resists depending on the lithography technique being used;
they can be classified into two categories: positive and negative resist (see figure 1.5). Neg-
ative moulds have the channel left behind whereas positive moulds have the inverse of the
channel design. In this thesis, a negative photo resist was used to fabricate PDMS devices by
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soft lithography. Mask quality can be chosen depending on feature size, for ten to hundreds
of microns an acetate mask is suitable whereas for geometries with much smaller feature
sizes a higher resolution mask, aka a quartz mask.
Figure 1.5: A schematic diagram illustrating the difference between positive and negative
photoresists used in photo-lithography
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Initially the main attraction to microfluidic devices is the high throughput experimen-
tation and that they are economically desirable due to being: cheap fabrication costs and
require low volumes of reagents and create very little waste. This is an attractive quality for
diagnostic and drug development applications. As mentioned previously, due to the micro
scale of the channel, flow will always be laminar according to the equation 1.1 for determin-






where, ρ is the density, u is the velocity, A is the cross sectional area, P is the wetted
perimeter and v is the viscosity of the fluid. If the Re < 2000 the flow is considered laminar
and due to the size of the microfluidic devices, the Re number will never exceed this thresh-
old [?]. Re number takes into consideration parameters that influence flow, allowing for the
comparison of different fluid properties and relative velocities. This will be useful when com-
paring a simple fluid with larger scaled vessels, denser fluid, reduced viscosity and velocity,
characteristics apparent in different animal models and in vitro conditions. Further develop-
ment of microfluidic technologies have allowed the field to advance into drug development
with the ability to carry out single cell analysis [64] and advance into organ on a chip in vitro
models [65], thus aiming to reduce the need for extensive in vivo animal research. There have
been some highly complex biological models, with the integration of cells. These are either
2D cultures or co-cultures, however they have advanced into tissue arrays with co-cultures
of cells and the extra cellular matrix [66]. A few of examples of these are: cardiac muscle on a
chip [67], lungs on a chip [68] and spleen on a chip [69]. It is evident the physical conditions
in which the cells are cultured within the chip influence cell phenotype and extracellular
matrix constituents [70, 71, 68]. It should be noted that this level of complexity has not yet
reached vein on a chip investigations due to the intricacy and difficulty of integrating valves
and pumps to microfluidic channels to mimic the physiology of the venous system. Within
microfluidics it has been recognised that the dynamic environment aids with the cultiva-
tion of cells which better represent in vivo cell biomarkers. This is a very attractive concept
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as a living organism is dynamic, with chemical and physical changes constantly occurring
and differing from person to person. For this reason microfluidic devices provide a micro
environment with scope to control many of the physical parameters to manipulate cells.
Microfluidic devices are becoming more popular in blood flow studies, whether it be
looking at rheology [72], platelet activation [73], white blood cell activation, red blood cell
aggregation as well as chemical responses in drug discovery and delivery studies [74]. The
micro-environments make it easier to visualise cellular responses. There is also an abun-
dance of research into arterial thrombosis, in vitro. Microfluidic devices have helped de-
termine biochemical processes behind arterial thrombus formation as well as biophysical
parameters. Investigation into physical parameters include differing the shear rate to study
platelet activation and accumulation [75, 76, 73]. It has also been possible to use microflu-
idic devices to look at protein expression in response to shear rate resulting in the platelet
activation [77] and adhesion [78]. All studies show that high shear rates increases the num-
ber of platelets sticking to the channel walls [78, 72, 75, 79]. The shear can be increased by
altering the velocity or viscosity of the fluid through the channel. Generally, when investigat-
ing platelet adhesion/aggregation whole blood is not used, and instead platelet rich plasma
(PRP) is used [72]. Plasma is a lot less optically challenging to work with as the fluid itself
is relatively transparent and the platelets can be fluorescently labelled to enhance the flow
detection and allow for the quantification of platelet adhesion and aggregation based on the
fluorescent signal.
Currently there has been no investigation using in vitro conditions due to the high vari-
ability with in physical parameters. The velocity of the blood through veins is variable de-
pendent on multiple environmental conditions such as: position of body, fluid intake [80],
health of patient: inflammation, infection and age. This variability can be mimicked us-
ing microfluidic devices and will allow for the examination of physical parameters leading
to pro-thrombotic conditions. Microfluidic flows can be easily manipulated using pressure
controllers and syringe pumps, ensuring full control over the velocity. Having complete con-
trol over the velocity is advantageous when mimicking the variable conditions in the veins.
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However, in vitro microfluidic blood flow will have a considerably lower Re number than a
large mammal case (in vivo). This is because according to 1.1 Re number is determined by
the size of the vessel and in a microfluidic case this is in the scale microns whereas blood
vessels of large mammals (e.g. humans) is ≈11 cm [81]. To over come this limitation, finite
element modelling can be implemented to exceed the boundaries of the experimental set up
(discussed later in section 1.4).
The idea of a bypass and thrombosis appears to be only touched upon in literature [56].
Maddala et al use a basic ladder microfluidic device. Within this study they use finite element
modelling (discussed later in section 1.4) to help understand the blood flow which is causing
the thrombus formation. Using finite element modelling, FEM in this way overcomes the
issues of visualising blood flow within the microfluidic channels. It was found that geomet-
rical factors influence thrombus formation [56]. They state that their model shows stagnant
regions and points of high shear, however the geometry itself is a ladder which is not rep-
resentative of an in vitro network of blood vessels. It was found that the platelets occur at
the regions of high shear, on the corners of the ladder network. Within this thesis, complex
microfluidic devices are designed with flexible valves as well as static systems which have a
side branch rather than a ladder network. Even though valves have not been reported in the
IVC of a mouse they are present within the venous network [57], however thrombosis does
not occur. Assuming that this is due to longitudinal flow of blood along the mouse body back
to the heart, then surrounding veins may also be valveless, this would allow for a bypass to
happen.
1.3.2 Evaluation of Flow
There are multiple ways to track flow through a microfluidic device, the most common being
particle tracking velocimetry, PTV, particle image velocimetry (PIV) and micro-particle im-
age velocimetry, µPIV, [82, 83]. Unfortunately PTV requires particles to be optically resolved
as it relies on the tracking of individual particles; this is therefore not useful for analysis of
flow through microfluidic devices [84]. Generally, fewer particles is beneficial for PTV. PIV,
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however tracks velocity fields using pulsed lasers then recorded using charge coupled de-
vice, CCD [85, 86] and complimentary metal oxide semiconductor, CMOS [87] cameras. Both
cameras have a series of random errors, of which CMOS performed slightly better on single
particle image in an interrogation window containing 10 particle images in PIV [88]. In PIV a
displacement vector for a window within the region of interest generally consists of multiple
particles in comparison to PTV which uses a lower concentration of particles. In order to
determine the displacement vector in PIV the signal is processed using a cross-correlation
algorithm, converting the signal into a velocity using the time between the pulsed laser and
the pixel size and taking an average [89, 90, 91]. A main limitation of PIV is the inability to
track flow within the z-plane making it difficult to determine velocity profiles for turbulent
flow [89, 92].
The advancement from PIV into µPIV overcomes the major limitation of having to have
each individual fluorescent tracer in plane making it a popular choice for microfluidic flow
visualisation [83, 84]. For µPIV it is important that particles are small enough to follow the
flow field religiously, therefore fluorescent 300 nm particles are a good choice [83]. When
using such small particles it is key to consider the effects of Brownian motion, to account for
this error depending on the diffusion coefficient (equation 1.2) [93].
D = K T
6πηR
(1.2)
Where K is the Boltzmann constant, T is the temperature and η is the viscosity of the liquid.
The mean square distance of diffusion, 〈s2〉 is calculated as [83]:
〈s2〉 = 2D∆t (1.3)
where the time intervals ∆t are much greater than Brownian motion meaning that the rela-











where u is the velocity and x is the pixel position. Equation 1.4 indicates the lower limit of∆t
and large velocity gradients will have much more complicated errors to consider with regards
to Brownian motion [83]. All these imaging techniques use cross-correlation algorithms to
track the particles from frame-to-frame [94]. In order to have a successful cross-correlation
algorithm the following parameters need to be considered: a statistical measure of the most
probable particle displacement, a mean of particle displacements is taken, giving a vector
[95]. Generally, when tracking blood flow in vivo or in vitro PTV or µPIV [96] are used. In
general it would seem that microfluidic technologies are favoured for investigating blood
flow in complex geometries.
Ghost Particle Velocimetry
Ghost particle velocimetry, GPV, is a relatively new technique for analysing flow [84]. Un-
like the typical techniques PIV and µPIV, GPV does not require a complicated experimental
set up and expensive lasers. Instead GPV only requires a bright field microscope and a high
speed (CMOS), camera to capture a ’speckle pattern’ obtained from particles smaller than
the diffraction limit (<300 nm). The physics behind the acquisition of the speckle pattern
is similar to that of dynamic light scattering, DLS [97]. DLS is a well established technique
that utilises the Brownian motion and the time correlation of the scattered light intensity
to determine the size of particles [84]. When coherent light hits a particle it is scattered
in all directions causing constructive and destructive interferences with the light scattered
by the surrounding particles resulting in intensity fluctuations which can be visualised as
a speckle pattern [98]. Depending on the time it takes for the displacement of the particle
due to Brownian motion will enable the quantification of the size of spherical particles in
suspension. The mobility of particles undergoing Brownian motion can also be described
as the diffusion coefficient, D, which is affected by the radius of the particle, R through the
Stokes-Einstein equation 1.2 [93].
It is not possible to precisely know how each particle moves in solution from the scattered
light. However, the movement of particles is relative to each other therefore a mathematical
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function called autocorrelation is used to indicate how similar scattered light, Is at time, t, is
to itself after a time interval, t’ which can be defined as:






Is(t )Is(t + t ′)d t (1.5)
DLS has C (t ′ →∞) as the baseline autocorrelation function which is dependent on the de-
tector area, optical alignment and scattering properties [98]. Assuming it is a mono-dispersed
suspension of spherical particles the autocorrelation of scattered light signal is represented
by an exponential decay curve [98, 93]:






+C (t ′ →∞) (1.6)
where τ is the characteristic time constant of the above decay function. τ is also related to
the diffusion coefficient, D:
τ= (2Dks)−1 (1.7)
where ks is the scattering wave vector which (for completeness) can be defined by the fol-
lowing:






where n is the refractive index of the liquid, λ is the wavelength of the light in a vacuum and
θ is the scattering angle [98]. The relationship between equations 1.2 to 1.7 is used in and
scattered light [98]. DLS combined with microscopy has been used to study the properties
of blood cells [99]. One limitation of DLS is that it requires an advanced optical set up with
lasers.
It is now possible to determine particle size and viscosity of a fluid using a standard
bright field microscope by a technique called differential dynamic microscopy, DDM [3].
DDM enables the quantification of sub-resolution nanoparticles using simple bright field
microscopy [3]. Brightfield microscopy generally use halogen or more recently LED light
sources to illuminate the sample with white light, in-coherent light. However, Cerbino et al
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overcame this issue by developing a method by simply quantifying the speckle pattern from
the scattered light without the need of any expensive lasers or filters [3]. Firstly, the light is
focused into a Köhler illumination. Köhler illumination is required to ensure a uniform dis-
tribution of light over the region of interest (ROI), which is important to obtain high quality
images. Secondly, the numerical aperture of the condenser lens, N Ac is closed to 0.2-0.3 ma-
nipulating the in-coherent LED light into a ’partially coherent’ light path. This manipulation
of light was determined by Cerbino et al for DDM [3]. The more closed the N Ac the better
the speckle pattern.
However, with regards this becomes a disadvantage to GPV as the speckle pattern will be
acquired over multiple focal planes according to the equation:
δz ≈λ/(N Ac )2 (1.9)
where δz is the longitudinal speckle characteristic size µm and λ is the wave length of light
(nm). It is desirable within GPV to have uniform motion at velocity, v over one focal plane
enabling the possibility to develop 3D flow profiles throughout a microfluidic device [84].
This is the reason the N Ac is opened to 0.15 to produce a depth of correlation of δz ≈ 20µm
[84].
In order to track the speckles over time multiple images need to be taken at the same
frame rate. For DDM, 1000 images were acquired at time intervals 10 and 200 ms(1.6). By
taking the average of 1000 frames gives the static contribution (figure 1.6 a) which can then
be subtracted from each frame enhancing the speckle pattern seen in figure 1.6 b and c. This
step also eliminates any static contribution, ’dirt’ observed in the original sample as seen
from figure 1.6 a, as black dots. This process is discussed in more detail in the Methods
section (2.2.3).
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Figure 1.6: An example of the imaging process carried out for DDM. Starting with a) the static
contribution, b) speckle enhancement image when the static contribution is subtracted from
one of the 1000 frames at 10 ms and finally c) for frames which are 200 ms apart [3]
GPV tracks flow within microfluidic channels meaning that the speckle pattern under-
goes a spatial translation v∆t , meaning that as long as the velocity is greater than the in-
fluence of Brownian motion, it can be neglected as the time correlation function becomes
a product of the displacement vector ∆x along the flow direction[84]. This then produces a
peak at ∆x = v∆t which can be cross-correlated from frame to frame in the same way PIV
and µPIV works in equation 1.5. Thus, highlighting the lower limit of GPV as a velocimetry
technique.
Capturing the speckle pattern is also dependent on frames per second, fps of the cam-
era, which is also its biggest limitation [100]. Riccomi et al concluded that GPV is limited by
camera performance and carried out numerous validations of the consistency of the cross
correlative velocity magnitude over 500 frames as well as comparing results with µPIV [100].
It was subsequently found that GPV is an excellent reliable technique for measuring flow
with relatively low velocities [100]. However, these experiments were also carried out within
a larger device (channel depths of 1 and 2 mm) meaning the signal to noise ratio will also be
greater as the interference from different planes will also affect the results. For this reason,
it is the detection technique of choice for the following experiments as not only are the ex-
periments within range of the Re number, the majority of the channels used are no deeper
than 150 µm. This means there is a significantly higher signal to noise ratio and field of view
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is less of an issue because the devices are notably smaller.
Another advantage of GPV over other particle velocimetry techniques is that the parti-
cles are small enough that they do not interfere with the fluid properties. This is advanta-
geous for wanting to detect complex flow patterns with in small devices [101, 102]. It has
proven a very useful technique for detecting vortexes in droplets and for investigating the
efficiency of mixing in microfluidic droplet formation [101], therefore making GPV an ap-
propriate technique for investigating fluid flow around micro-structures both solid [103] and
flexible (proved within this thesis).
1.4 Computational Fluid Dynamics
As technology is advancing the ability to match the dynamic complexity of living systems is
becoming more feasible making computational fluid dynamics, CFD a more attractive tool
in biomedical research. Simulations that used to take days to compute are now only taking
hours, and sometimes even minutes (depending on the complexity of the model). CFD is
used throughout engineering to aid the design of industrial plants, improving the efficiency
of production and maintenance. The cardiovascular system is a complex network of pumps,
valves and pipes, as discussed earlier, however the complexity arises from the varying ma-
terial properties, the constituents of blood, position in the body and surrounding tissues (to
name a few). Essentially there is large variability from person-to-person, however using CFD
enables a multitude of parameters to be investigated in order to determine a pathological
outcome. CFD models can be split into two methods, meshed and mesh free simulations.
1.4.1 Mesh Simulations
Finite element methods (FEM) are very popular when trying to understand fluid flow [104].
The mesh is an important aspect when carrying out FEM simulations. It subdivides the total
volume in to smaller volumes called elements. Elements can be 1D, 2D or 3D, this thesis
uses gmsh for mesh development, which uses a 2D triangular and 3D tetrahedral meshing
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geometry. This has been used widely in previous FEM simulations of blood flow [105, 106,
107]. It has been noted that tetrahedral geometries are common for modelling fluids [106,
108, 107]. The nodes are the vertices of the shape (highlighted in figure 1.7).
Nodes
Figure 1.7: A visual representation of elements, nodes and boundaries typically used in FEM
simulations
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The optimisation of a mesh is highly important when running FEM simulations. It can
be optimised with localised refinement across the geometry. When using FEM for modelling
biological valves there are two main things to consider: 1) solid structure and its material
properties, 2) the surrounding fluid and its viscosity and density bring rise to a highly com-
plex fluid structure interaction problem. In order to simulate blood flow in a vein there are
two main algorithms to consider: conforming mesh (figure 1.8a) methods and non conform-
ing mesh methods (figure 1.8b).
• Conforming mesh methods divide the mesh into two parts: one for the solid valve
where the deformation equations are solved and the other for the fluid where the
Navier-Stokes equations are solved. This means that the mesh will move with the
boundary [109].
• Non-conforming mesh methods is an Immersed Boundary Method where the mesh
does not move with the boundary and the movement of the interface between the solid
and liquid is accounted for using forcing terms to the governing equations of the fluid
motion [109].
A major disadvantage to a conforming mesh is that it can become computationally expensive
due to the constant need for re-meshing at the solid-fluid interface. This being said, as the
majority of simulations within this thesis are 2D, it is possible to use the conforming mesh
approach.
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Figure 1.8: A mesh representation showing the differences between a conforming mesh ap-
proach (a) and a non-conforming mesh approach (b). Figure taken from Ariane et al 2017
[4]
Both conforming and non-conforming simulations have been used for modelling the
cardiovascular system. It would seem that the most advanced models are for the heart [110,
109] and arteries and similarly to in vitro research there is a distinct lack of research into the
venous system. There are some rather elegant finite element simulations for understanding
blood flow around and out of the heart. This has been useful to determine how stiffness of
valves and vessel play an important role at pumping blood around the heart and through
the aorta to the rest of the body [110, 111]. This has lead to an extensive understanding
to many cardiac diseases, including for the investigation of the efficiency of artificial valves
[109, 112]. It is now possible to use magnetic resonance image, MRI to obtain specific ge-
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ometries of the heart for CFD modelling, aiding in the preparation of surgical procedures
[113]. The progression in technology and understanding of in silco research is a powerful
tool for the optimisation of surgical procedures and determination of suitable implantation
materials from person-to-person.
Thrombus formation within arteries is becoming increasing more popular within mod-
elling and simulation as CFD technologies are advancing [114]. Papadopoulos et al has de-
veloped a model of thrombus formation and growth simultaneously within veins alongside
blood flow, and concentrations of various substances [115]. This model assumes that throm-
bin generation occurs on vessel walls and the platelet surface, however does not account
moveable boundaries, such as venous valves. As the vessel is more complicated a more ad-
vanced modelling system is required to account for all the factors within veins, such as: flex-
ible valves, muscle pump, slow flow rate, various sized blood cells, activation of platelets,
etc.
1.4.2 Mesh Free Simulations
Mesh free simulations are relatively new to CFD bringing many advantages of the conven-
tional finite element simulations. Instead of using elements and nodes this technique utilises
a ’particle based’ approach. Discrete multi-hybrid system, DMHS is a novel “model-by-
models” simulation technique to link multiple parameters to achieve a complete represen-
tation of complex systems – like veins and blood flow [116]. This model-by-models approach
overcomes many limitations with current numerical models as it is mesh free. DMHS allows
for the simulation of solid-liquid suspensions-like blood as well as adding movable bound-
aries for the flexible valve flaps. There is high demand for these systems to further under-
stand flow around the heart, and perfect surgical techniques. DMHS also allows for certain
particles to become ‘sticky’ with in the model, which can simulate the thrombus forming
[4]. Ariane et al has carried out multiple DMHS simulations looking at both valve length and
stiffness and its effect on thrombus formation [4, 117]. They found that leaflet stiffness and
length play a crucial role in the initiation of thrombus formation.
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Figure 1.9: A figure showing different algorithms used to investigate clot formation. A) Uses
a ’calcification’ approach, B) is a free clot and C) is a ’filiform clot’ Figure taken from [4]
Unfortunately mesh-free methods are relatively new meaning there is less available in-
formation, expertise and software. However it is a highly attractive tool for the modelling of
biological processes, especially at fluid structure interfaces as it overcomes the major limita-
tions in mesh based simulations [116]. Due to the lack of information and software available
for mesh free simulations and the nature of this thesis (experimental and computational)
the focus will be on mesh based simulations to validate and extend from the experimental
findings.
It is safe to say that computational multi-physic simulations are leading the way in un-
derstanding flow around valves in venous flow conditions. They have been carried out using
various finite element and mesh free approaches. An advantage to using simulations is the
ease at altering minor changes to physical parameters or boundaries (e.g. geometries, elas-
ticity, friction, etc). The major drawback behind simulations is that they generally use ideal
situations to collect high quality data, this is not true to life therefore experimental valida-
tions are always desirable. Within this thesis it is used to validate the experimental results







All geometries were designed using AutoCAD (Autodesk Inc, US). Starting with the murine
model, microfluidic channels were designed with the following parameters: width 200-500
µm and a stenosis of 50-80% of the channels. Geometries with side branches and anomalies
(closed side branch) where also designed. The width of the channel was to match that of
the IVC of a mouse as much as possible (D ≈ 200µm). The reason for varying the degree of
stenosis was to determine whether or not it influences flow patterns which would be indica-
tive of thrombus formation, as reported in literature, the larger the stenosis the more likely
a thrombus is going to form. And finally the addition of side branches was to explore the
disruption of flow before the stenosis which is suggested to cause/prevent thrombus forma-
tion depending on the position of the side branch. By observing many possibilities it will be
interesting to see if there is any disruption to flow and whether or not this could be linked to
thrombosis. It will give an insight to development of thrombus formation with in a murine
model.
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Figure 2.1: A diagram illustrating the different stenosis, closed side branch geometries and
side branch geometries at the different positions.
Cylindrical Stenosis Device
Obviously, veins are not square so after the microfluidic devices were designed, 3D cylindri-
cal geometries were also designed to look at the effects of the curvature on flow. It should
also be noted that it is the aim to progress the model into a more ’human-like’ device and
for this reason 3D printing methods are going to be used. The geometries were designed
using AutoCAD, as before, and saved as an .stl file (see figure 2.2). Illustrated in figure 2.2 is
the dimensions of two half cylinders. This was to make the fabrication steps in 2.2.1 slightly
easier.
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Figure 2.2: A 3D CAD drawing of the cylindrical device at different angles A) is the top view
and B) illustrates the end of the channel where R = 0.5 mm and C) the stenosed region r =
0.15 mm
2.1.2 Bypass Model
To develop the device specifically for the bypass model, a bypass around the stenosis was
added at 3 different positions along the channel (see figure 2.3 and 2.4).
Figure 2.3: An example of a CAD drawing of the bypass geometry with the three different
positions of the 100 µm side branch, black = 300 µm, red = 600 µm and green = 1600 µm
away from the stenosis. Regions are labelled and L = 2.12 cm
Figure 2.3 is an example of the geometry used in the bypass experiments, however po-
sition was not the only parameter studied. The influence of side branch width (WSB ) was
also investigated, in order to do this a WSB = 200µm and WSB = 100µm was designed. The
example displayed above in figure 2.3 is the WSB = 100µm. Finally the degree of stenosis was
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also explored. In order to have control over the amount of stenosis over smaller increments
than in the stenosis model, a valve was added to restrict the main channel like seen in figure
2.4. Three pump geometries were tried.
Figure 2.4: The CAD image of the pump devices, the A) showing a curved design, B) the short
based pump (Lp = 500 µm) and the C) a long based pump (Lp = 800 µm) geometry
The three geometries were designed in order to determine the most efficient way to apply
a stenosis to the main channel. The curved base (top geometry figure 2.4 A), was designed in
the case that the PDMS was too stiff and did not close the main channel sufficiently to cause





The straight channel where width, w = 300µm had to be adapted to secure flexible valves in
place. The initial design used pillars to secure the valves and the second used an anchor (fig
2.5). The reason for the anchor is that the polyethylene glycol-diacrylate, PEGDA does not
cure in the presence of oxygen and as PDMS is permeable to oxygen there would be a small
gap between the PEGDA valve and the PDMS channel walls.
Figure 2.5: The CAD image of the geometries that were tested to secure the valves in place
The valves themselves were designed according to different scaling factors depending on
the magnification (see table 2.1).
Table 2.1: A table to present the scaling factors for designing the masks depending on objec-
tive used




There were two valves used throughout this thesis: a simple valve and a leaflet valve (see
figure 2.6)
33
Figure 2.6: The CAD images of the valve geometries used for in situ material characterisation
(straight valve) and flow studies (leaflet valve)
3D Printed Device
There were two 3D printed geometries, the first one aimed to print the whole geometry with
valves cut out with dimensions 4x4 mm. However this geometry was fabricated unsuccess-
fully and the depth was too great to visualise flow patterns. This was overcome by designing
two separate geometries for 3D printing. The first being a straight channel 2x4 mm with
length 12 cm and the valves printed independently of each other with slightly deeper 0.5x3
mm as seen in figure 2.7.
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Figure 2.7: The 3D CAD drawing of the static valve structures which were printed on the 3D
printer. L = 12 mm, H = 2 mm, W = 4 mm, w= 0.5 mm vB = 1 mm
The use of the microfluidic valve geometry for 3D printing is not possible due to the
valves being too thin to print. Therefore thicker valves were designed to suit the resolution
of the 3D printer (≈ 25µm)
2.1.4 Simulation Geometries
Geometries designed for the stenosis (microfluidic and 3D printed) model and valve model
were also used in the simulations. It was considered so to better replicate experimental con-
ditions extruded geometries were used at roughly the depth ≈ 100µm. However, due to lam-
inar nature of flow it was more time effective to run the majority of microfluidic simulations
in 2D geometries(results discussed later in section 5.5) especially when valves were added.
The valves used in the simulations were the geometries used to create the UV-masks. In
addition to the masks the valves were also rounded at the tip, to better replicate the experi-
mental conditions with the aim to duplicate results achieved in the microfluidic devices. The
geometries were imported in to the meshing software as an .igs file allowing the allocation of
points along the lines and add points for localised mesh refinement (figure 2.8 A1 and A2).
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The results of the addition of the points will be seen later in the section 2.3. The geometry of
the valves were slightly adapted to better replicate the experimental conditions. Instead of
using the sharp point in the mask, the tip was rounded slightly with the aim to achieve more
accurate results to validate the experimental assumptions (figure 2.8 B). Alongside the long
valves used in the experimental results a second geometry was designed directly into gmsh.
This was to look at the influence of shorter/thicker valves and the influence on flow (figure
2.8 C).
Figure 2.8: A Is the geometry with the valve geometry taken from the mask with A1 and A2
showing the points which have been added for mesh refinement. B is the curved valve and
C is the geometry for the short thick valves
Once the geometrical entities are drawn the physical groups need to be defined before
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a mesh can be created. These physical groups are the: valves, channel walls, inlet, outlet
and the fluid. Each physical group is given a surface in which a mesh can be applied. The
groupings then enable the setting of boundary conditions in the section 2.3. Points can also
be made physical groups and mesh refinement can be set around them, these points have
been added in order to increase the resolution of the calculations around the point where
interesting flow patterns could occur.
2.2 Fabrication of the Device
2.2.1 Main Channel
Conventional soft lithography techniques (see figure 2.9) were used to fabricate polydimethyl-
siloxane (PDMS, Sylgard® 184 Silicon Elastomer Kit, Dow Corning, UK) devices. Firstly, 5 g
of SU8-2075 (MicroChem, Westborough, USA) was added onto a silicone wafer (d=100 mm,
Si-Mat, Germany) and spin coated at 1750 rpm. Microfluidic devices need to be fabricated
using a clean room to reduce the risk of dust contamination, which consequently improves
reproducibility of the channel depths as there is strict environmental control, temperature
and humidity. Unfortunately the SU8-2075 degrades over time, meaning that even though
there was strict environmental control there was slight variance in channel depth over time.
Once there an even spread of photo-resist across the silicon wafer is achieved, it is soft baked
for 5 mins 65 ◦C followed immediately after by 35 mins at 95 ◦C. Then the photo mask (Micro
Lithography Services Ltd, UK) is aligned with the silicon wafer using a mask aligner (Canon
PLA-501FA Mask Aligner) and exposed to ultra violet, UV, light for 2x40 seconds. There was
a break between each 40 second exposure to prevent cracking of the photoresist. The silicon
wafer the underwent further baking (3 mins at 65 ◦C and 12 mins at 95 ◦C). Finally the chan-
nels can be developed using SU8 developer (MicroChem, Westborough, USA) and washed
with isopropan-2-ol (Sigma Aldrich, UK). This creates a master mould, which can be reused
for soft lithography microfluidic devices.
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Figure 2.9: A flow diagram of the photolithography process carried out in the clean room
The PDMS and curing agent was mixed together (10:1 ratio) and poured onto the master
mould. Degassing of the PDMS was carried out under vacuum. Once all the gas has been
removed the coated master mould was baked for 1.5 hrs at 70 ◦C and left over night at room
temperature to be used the following day. However, if the devices were required for use in the
same day, the curing in the oven was increased to 3 hrs to ensure full curing of the device.
The PDMS channel is then cut and pealed away from the master mould creating the top
layer of the microfluidic device. Inlet and outlet holes are punched into the PDMS with a
biopsy puncher (1.5 mm, Miltex by Kai) and plasma treated using a corona discharge (PZ2
Handheld Device, Relyon Plasma GmbH, Germany) before being bonded to the bottom layer
of the device (glass slide or PDMS). To encourage this binding process the whole device is left
on a hot plate at 80◦C under a 50 g weight for ≈30 mins. Special care needs to be taken to
ensure the curing temperature is constant throughout the fabrication of all devices but in
particular the bypass geometries. It is reported that curing temperature affects the elastic




The 3D device moulds were printed using a laser 3D printer (Form 2, Formlabs, England)
with a laser spot size of 150µm and a layer height of 25− 100µm which meant to achieve
the best resolution for the stenosed region the geometry was aligned directly on top of the
printing plate with the 3D printer scanning along the x, y plane illustrated in figure 2.10.
Figure 2.10: A not to scale picture showing the Form 2 3D laser printer used for the fabri-
cation of the cylindrical devices, along with geometry orientation on the printing place A)
without a base and B) with a base. The printing direction is a raster along the x, y plane. D =
1 mm
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Once printed the mould is then washed using soap and water to remove excess monomers
that prevent curing of the PDMS. Then PDMS is poured onto the mould as described in
method 2.2.1. Firstly the half cylinder was adhered to a glass slide same as for the microflu-
idic channels, however the fabrication of a full cylinder is more complex. The mould with
the base had the most accurate geometry as when printed directly onto the printing plate
there was a slight angle during the printing process affecting the diameter of both the main
channel and stenosis. For this reason the channel was printed onto a base which can be seen
in figure 2.10 B. The half cylinder was printed twice in order to create the top and the bottom
of the device as indicated in figure 2.2 previously. Due to the size of the stenosis region a
microscope is required to enable a precise alignment of the top and bottom PDMS devices.
Early attempts, although aligned, when left on the hot plate to secure the two channels were
not adhering to one and other. Initially it was thought that when carrying out the corona dis-
charge treatment of both sides of the device that the surface functionalisation was not lasting
long enough during the alignment process. It is reported in literature that the hydrophobic-
ity induced by the corona discharge treatment only lasts for a limited time [119]. In order
to prolong the functionalisation of the PDMS surface from the corona discharge, water was
added. Unfortunately, the adhesion did not occur with the addition of water to the surface,
it was thought that this was due to the slow evaporation of water from the two channels.
Ethanol was then tried and although slightly better the two channels could still be peeled
away from each other easily. This lead to the final conclusion that the surface roughness of
the base was the parameter preventing the adhesion of the two PDMS cylindrical channels.
Therefore within this thesis, only half a cylinder is going to be investigated experimentally to
observe the effects of a 3D stenosis on the fluid flow.
Valve Design
The straight channel mould was printed in the same orientation as seen in figure 2.10. There
was no need for a base as this was a simple rectangular channel compared to the more com-
plex stenosis geometry. The valves were slightly more intricate; they required support struc-
tures and printed at 45◦ angle. Various positions were tested in order to ensure that the valves
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themselves were printed with precision and symmetrical on both sides. The device assembly
was also complicated. The valve structures had to be adapted to ensure an exact fit with in
the channel. If the valves were not a snug fit there would be excess flow around the valves
which is not seen in the microfluidic devices making them incomparable. If the valves were
excessively big they would prevent the adhesion of the channel to a glass slide and result in
air bubbles occurring in the channel. Although corona treatment was used, it did not secure
the channel to the glass slide and for this reason Araldite® Epoxy Adhesive (Araldite Pro-
fessional Adhesives, Switzerland) was used along with a clamp to prevent bubbles forming
within the channel.
In Situ Fabrication of Flexible Valves
Stop-flow lithography was used to fabricate flexible valves in situ to the microfluidic chan-
nel [120]. The channel was injected with polyethylene glycol-diacrylate (PEGDA; Mw ≈
575, Sigma Aldrich, UK) and photo-initiator, PI, 2-hydroxy-2-methyl propiophenone (Sigma
Aldrich, UK). The PI enabled the polymerisation of PEGDA when exposed to UV light (λ ≈
365 nm). To ensure there were no air-bubbles within the device a second syringe was added
to the outlet to add a counter pressure, pushing the air out of the channel. The device was
then left until the flow had settled (usually about 2 mins). Once the flow has stopped it
is possible to align the mask with the channel (fig. 2.11). The mask is positioned at the
conjugated plane in the epi-fluorescence light path of the optical microscope (Nikon Ti-U,
Japan) and illuminated with an LED source containing a UV band (SOLA-SE-365, Lumen-
cor, USA). To align the mask with the channel and prevent premature curing, a filter was
used λ = 545± 25nm The filter was then switched to allow the selection of the UV wave-
length λ = 350± 50nm to cure the PEGDA into the desired geometry. This whole process
was carried out using x20 objective. PEGDA does not polymerise in the presence of oxy-
gen [121]. As PDMS is oxygen-permeable, a thin layer of PEGDA (about 3 – 5 µm) remain
liquid after UV exposure. This guarantee the possibility to fabricate valves that can move
freely but also require a geometry (pillars or anchor) to keep them in place. The lowest ex-
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posure time required to achieve the best resolution was adopted, in our case 300 ms. The
exposure time is dependent on the concentration of PI and was found to have a linear re-
lationship between concentration and exposure time [122]. In order to create asymmetrical
valves each leaflet was fabricate separately. We used a mask for each leaflet and control the
characteristic of each one independently by modifying PEGDA or PI concentration or UV
exposure time.Finally, after valve fabrication, the channel was flushed with water and the
whole device was submerged in water to preserve hydrogel properties until the experiment
was performed, and in any case for no more than 24 hours.
Figure 2.11: A schematic diagram illustrating the method behind the in situ fabrication of
flexible PEGDA valves
Once valves had been fabricated it was important to characterise them in situ. With vary-
ing concentrations of both PEGDA and PI it then possible to determine the material prop-
erties of the valves. This was carried out similar to that by Wexler et al., [122]. It is possible











Where D is the depth of the channel, µ is the velocity, Q is the mass flow rate (m3/s), H is
channel width, d is the depth of the valve, w is the width of the valve (as seen in figure 2.12),
c = h/H and u(c) = εc5( π16 − 245 ) ≈ 0.15εc5 therefore u1 = 0.15∗ (0.4)5 ∼= 0.0015 as it is linear
contribution that is considered (small deflection). It is the small deflection that we can use
to calculate E [122]. The reason for using small deflection is to allow for the measurement of
deflection as a function of dimensionless fibre height c = h/H using u1(c). [122].
Figure 2.12: A 3D (A) and 2D (B) diagram illustrating the parameters used in equation 2.1.
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2.2.2 Experimental Set up
Figure 2.13: A schematic diagram demonstrating the experimental set up including syringe
pump to control flow rates, microfluidic device and waste collection. Although fluid here is
illustrated with blue, in actual experimental set up appear to be white PS particles due to the
scattering of light off the nanoparticles making the solution translucent
Stenosis Model
Each inlet to the microfluidic device was connected to a 5 mL syringe (Becton Dickinson
hypodermic syringes, polypropylene, Sigma Aldrich, UK) and tubing. The outlet’s tubing
was directed to a waste vial (figure 2.13). The syringes were placed into a syringe pump. For
the branched devices two syringe pumps were used to control the flow rates independently
to each other. Two cameras were used to optimise the experimental set up for the most
efficient data collection process. The two cameras were the SA5 and SA3 photron CMOS
cameras (Photron Europe Limitted, UK).
Whole Blood Preparation
Blood samples were taken from healthy volunteers approved by the Ethics Committee for re-
search in to DVT. Under Alexander Brill (Institute of Cardiovascular Sciences, University of
Birmingham) (ERN 11-0175)
In the branched geometries whole blood (5 mL from healthy volunteers) treated with
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ethylenediamine tetra acetic acid, K2EDTA (10 µL of 20 % (v/v) K2EDTA solution for 1 mL) to
prevent clotting and Dulbecco’s phosphate-buffered saline (DPBS) with no calcium or mag-
nesium. This is because the presence of calcium ions encourages clot formation [123]. DPBS
and whole blood was pumped through the different inlets of the branched geometries.
Blood Plasma Isolation
Whole blood was collected and prepared as above in section 2.2.2. Then in order to isolate
the blood plasma, whole blood was added to polypropylene tubes (10 mL per tube) and cen-
trifuged at 200x g for 20 mins at room temperature. As platelets are smaller than other cells
within whole blood they remain at the top after centrifuging. The top layer, which is the
platelets and plasma before centrifuging again at 2000x g for a further 10 mins. Platelets will
pellet at the bottom of the centrifuge tube allowing for the removal of the blood plasma su-
pernatant. Care was taken not to disturb the pellet. Blood plasma was used the same day of
collection and isolation.
Bypass Model
The syringe pumps and microfluidic channel was connected in the same way as in section
2.2.2 for the non-pump design. Flow rates 1-10 µL/min and 5-100 µL/min were investi-
gated in the side branch whilst the main channel remained at 10 µL/min and 100 µL/min
respectively. These conditions were then switched to investigate a variety of possibilities.
The pump inlets were connected to a pressure controller (OB1 MK3, Elveflow, France) sim-
ilar to that described above. The pumps were also filled with fluid (ink) to ensure there was
no air which could be pushed through the PDMS into the main channel, creating bubbles.
Ink was used to enable to visualisation of fluid.
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Figure 2.14: A microscope image of demonstrating the pump channels filled with ink. Scale
bar = 75 µm
To induce a stenosis within the channel the microfluidic device was connected to the
pressure controller the pressure was changed from 0-1900 mBar to constrict the main chan-
nel for the pumps and flow rate was controlled by applying 50 and 30 mBar to the main
channel and by the side branch. Initially GPV was carried out to visualise the bypass occur-
ring as a result of differing flow rates. However, when investigating the bypass as a product




Two flow conditions were investigated within the valve model: continuous and pulsed flow.
First, the continuous flow experimental set up used the syringe pumps which were con-
nected via the method described in section 2.2.2. Flow rates 0-900 µL/min were investi-
gated to characterise the stiffness of the simple valve. The range was then reduced to 20-400
µL/min for the visualisation of flow patterns through the valves. These two experiments lead
to the investigation of pulsed flow on the flexible valves. Pulsed flow was used to investigate
the flow patterns on opening and closing of valves as well as particle accumulation.
2.2.3 Flow Visualisation
Microscope set up
The microscope (Nikon Ti-U, Japan) was set up for GPV. In order to do this, first the device
needs to be in focus with a x20 magnification objective before focusing and centring the
light into Kohler Illumination. Then the numerical aperture of the condenser lens, N Ac was
reduced to optimise the visualisation of the speckle pattern, as mentioned in section 1.3.2.
The position was just under half-way closed, which was estimated to be around N Ac = 0.15
and 0.20 which equates to a speckle diameter of≈ 3µm [124] for a height, H ≈ 100µm. For the
3D printed milli-fluidic devices the aperture needs to be closed more due to the interference
of scattered light from other planes. After the microscope is set up for speckle detection, it is
then possible to capture the flow.
Image Processing
It is possible to enhance the speckle pattern using ImageJ [5]. In literature 1000-4000 frames
were recorded [84], however the channels were quite a bit deeper than the channels used in
these experiments (70-135 µm) therefore only 100 frames were captured and validated (see
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section 3.1.1) to ensure that this was sufficient for measuring accurate velocity profiles. The
static contribution can be obtained by subtracting the median from each of the frames. This
process removes any dust on the camera lens/objectives (see figure 2.15) [84, 5].
Figure 2.15: Flow diagram showing the image processing carried out using imageJ for GPV[5]
Data Analysis
It is then possible to track the speckle pattern from frame-to-frame, 1-2, 2-3, 3-4...etc us-
ing an open source matlab programme PIVlab [125]. PIVlab is commonly used as the title
suggests for particle image velocimetry, as it uses the same cross-correlation calculations
[126, 127, 84].
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Figure 2.16: A visual of the standard procedure carried out using PIVlab. A) indicates where
the ROI can be set and B) where the mask can be set. This can be drawn manually or im-
ported. C) Is where it is possible to set the area at which an average of vectors can be con-
sidered. With this example a small area can be used as the GPV is of a high quality. After the
analysis has occurred and vectors have been computed. Post processing can occur. Firstly,
D) the calibration of the velocity to operate in m/s compared to pixels per second along with
the setting the reference distance. Finally E) vector validation to remove anomalies
Firstly, a mask is applied to each of the images to exclude regions without flow (figure
2.16 A). The mask is applied to every frame. A ROI can also be isolated in order to inves-
tigate a specific region. Secondly the cross-correlation calculations are computed between
each frame and then data processing can occur. PIVlab plots vectors by taking an average of
surround pixels. The area at which the mean vector is taken was dictated by the parameters
inputted into PIVlab. This parameter is specified within as ’interrogation area’ and depend-
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ing on the quality of the data can be manipulated. The smaller the region the lower number
of pixels are averaged and therefore more accurate the data. In most of this thesis the inter-
rogation area is usually set to 16 pixels. Vector validation is carried out to keep the vectors
which are corresponding to flow figure 2.16 E). In order to calibrate the vectors channel di-
mensions need to be imputed as well as frames per second instead of frames per pixel using
the following equation:
pi xel sper second = 1
f ps
(2.2)
One validation approach is to ensure that the experimental velocity is matching the theoret-




Where u is the velocity, Q is the volumetric flow rate (m3/s) calculated from the flow rate set
by the syringe pump and A is the cross sectional area of the microfluidic channel (W ∗ H).
Obviously there was an increase velocity through the stenosis compared to the rest of the
channel, this resulted in two data sets having to be taken per device in order to capture the
flow through the restriction and the main channel. One frame rate was used to acquire flow
through the main channel and a higher frame rate was used for through the stenosis. The
second way to validate the GPV results is to ensure there is little difference from frame to
frame and velocity measurement [100]. Finally the third validation is the use FEM to back up
the experimental findings.
2.3 Simulation
Various open source software was used to carry out finite element, FE, multiphysics simula-
tions. For the stenosis model 2D and 3D simulations were carried out and the valve model,
only 2D simulations. Once the geometry is drawn as seen in sections 2.1.1 and 2.1.3 they
can be exported from AutoCAD as a .iges file into to an open source meshing software Gmsh
[128]. Gmsh is used for tetrahedral meshing and is recommended by the multiphysics soft-
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ware Elmer [129]. Elmer is a finite element software meaning it requires a mesh to carry out
the simulations. Once the mesh has been optimised in gmsh it is exported as a .msh file and
can be opened in Elmer to start a new project. The use of a mesh-based simulation meant
that simulations were relatively quick due compared to more complex particle based meth-
ods. It was also easy to set boundary and body (i.e. fluid and solid) conditions. The equations
and material properties can be directly applied to bodies (fluid and valves).
Murine Model
For the stenosis model a steady state model was solved using the Navier-Stokes equation.
The Navier-Stokes equation is based on fundamental principles: conservation of mass, mo-
mentum and energy. In brief, it comprises of momentum and continuity equations as well
as taking into consideration stress tensors for Newtonian fluids. Within this thesis it is recog-
nised that blood is a non-Newtonian fluid, however to act as validation for the experimen-
tal model Newtonian flow conditions where used. Constants are set as prerequisites of the
model and are stated in table 2.2.
Table 2.2: Necessary values to remain constant throughout all simulations
Prerequisite Value
Stefan Boltzmann 5.67e−08
Permittivity of Vacuum 8.8542e−12
Boltzmann Constant 1.3807e−23
Unit Charge 1.602e−19
The flow within the device is also assumed to be non compressible. Therefore the pro-




+ (~u ·O)~u −O · (2µε)+OP = ρ~f ,O ·~u = 0 (2.4)
where ρ is the density, ~u is the velocity, ε is the strain tensor, p is pressure, t is time the






In ElmerFem it is suggested that the flow in the x direction (vx) is where to set the desired
velocity, and as this is laminar flow flows within the y and z direction (vy and vz) can be
set to 0 as it is assumed that there is no gravitational affects effecting vz on the flow and
due to laminar flow conditions there should be no other forces pushing the flow in the y
direction. A parabolic flow regime can be set from the very start of the channel with the
following equation:
vx = 6∗ (t x −1)∗ (2− t x) (2.5)
Where tx is the inputted velocity. All boundaries were given a no-slip condition. At the outlet
only the vy condition is defined and is also set to 0.0 m/s.
The number of iterations was increased to 500 allowing more time for the simulation
to converge. The main body is given the material properties of water at room temperature
(298 K) meaning that the density was set to 1000kg /m3 and dynamic viscosity to 8.9∗10−4
Pa.s. The fluid is stated to be non-compressible. Due to the length of the channel before the
stenosis is long enough the inlet velocity does not have to be set to have a parabolic profile.
This was planned to replicate the conditions of the experiment. The parabolic profile occurs
over in the channel (see section 3.1.6). The boundary conditions were set as follows:
• Inlet = x velocity was set to the flow rate (m/s), y velocity was set to 0 as the flow is
laminar. The side branch geometry was given a second inlet parameter in order to
control the inlet velocities independently of each other.
• Outlet = setting the y velocity to 0. Although in the majority of simulations the pressure
is usually set to 1 atm, this is not necessary for these simulations
• Walls = No slip boundary conditions
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The number of nodes for each geometry is presented in table 2.3 and an example of the mesh
used throughout the simulations can be seen from figure 2.17. In the following mesh’s there
is no refinement factor throughout the main channels, however there is the same refinement
applied to the stenosis region. The refinement is a progression throughout the stenosis lines
































































































































































































































































































































































The valve model was slightly more complex as the deformation of the valves was added to
the simulation to replicate the experimental conditions. In order to add deformation, the
fluid body had to under go mesh deformations, while the valves underwent a non-linear
elasticity solver. An example of the .sif files will be added to the appendix (A.1). However, for
completeness, the boundary conditions are same as above, along with the added boundary:
• Valves = Given an non slip boundary condition for the Navier-Stokes equation, Elas-
ticity was varied to observe how elasticity may influence flow.
The quality of the mesh is crucial for FE simulations. For this reason various mesh’s were
tested and optimised. For the deformation studies the mesh was partitioned to attempt to
alter the two bodies (2.18 C), solid (valve) and fluid (main body). This partition would be
highly useful for understanding fluid-structure interactions. In order to ensure the solvers
are run in the correct order: flow solver, elasticity solver and finally the mesh deformation
solver. This will make sure that the ’solid’ bodies are responding to the force acting on them
(velocity) and then the fluid responds to the moving valve.
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Figure 2.18: Images showing the different mesh refinements for each geometry. A and B show
the valve which is taken from the CAD file for the photo-masks, C shows the mesh partitions
for the vavles and the fluid and D and E show the short thick valves to look at an extreme
geometrical change on the fluid flow
Table 2.4: A table to present number of numerical elements and nodes within each mesh
A-E, along with equations applied
Geometry Solver Number of Nodes on line Number of Surface Nodes Number of Elements Refinement
A Navier-Stokes 516 3449 7412 0.1
B Navier-Stokes 322 1080 2468 1 for majority of mesh
and 0.1 though valves
C Navier-Stokes 334 1148 2746 0.1 with refinement factor
Non-Linear Elasticity of a further 0.1 on valve
Mesh Deformation boundaries
D Navier-Stokes 140 597 1332 0.1
E Navier-Stokes 242 1891 4022 0.01
The number of iterations was also kept the same as previous simulations, however a re-
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laxation factor was implemented on the primary solvers (elasticity and fluid flow), of 0.5 and
the number of non-linear iterations to 1. This does not apply to the mesh deformation solver
as it just determines the displacement of the elasticity solver in response to the fluid solver.
The methodology for following both the murine and valve simulations was carried out sim-
ilar to that in the Elmer GUI tutorials [130] with parameters altered to match experimental
conditions.
Finally the analysis of the FE simulations was carried out using another open source soft-
ware, Paraview. Therefore, the output file was set to .vtu. Using paraview it is possible to





The stenosis model is a popular choice for in vivo studies of DVT, in particular the murine
model (discussed in detail 1.2.1). For this reason it seems an appropriate place to start de-
veloping an in vitro model. The purpose of this chapter is to 1) optimise the GPV set up to
capture 2D and 3D flow profiles, 2) use GPV to explore flow patterns before the stenosis to
investigate why thrombus formation occurs and 3) add complexity by investigating how the
presences of closed and open side branches may influence flow around the stenosis region
of interest.
3.1 Results and Discussion
3.1.1 Optimisation of GPV set up
The ability to detect the speckle pattern for GPV is dependent on the camera specifications.
Generally there is a trade off between fps and field of view meaning that as the fps increases
the field of view decreases. The camera has to reduce the resolution in order to raster in the
x-direction quick enough to achieve the higher fps. In this case two cameras were used to
determine which set up would be optimal for the future experiments. The two cameras were
the SA3 and SA5 mentioned previously in materials and methods section 2.2.2. It became
evident early on that the SA3 did not have the resolution at high fps required to capture the
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speckle pattern, even for the large devices (500µm), see table 3.1.
Table 3.1: A table presenting to performance of the CMOS cameras used for capturing GPV
SA3 SA5
Max fps 60, 000 1, 000, 000
Max Resoltution (px) 128 x 16 64 x 16
Required fps * 30, 000 30, 000
Resolution 256 x 48 768 x 320
The * seen in table 3.1 is to indicate the maximum fps used in the GPV experiments. As
seen in 3.1 the major limitation for both cameras is when the fps is at its highest the reso-
lution drops drastically. For the SA3 this happens a lot sooner than the SA5. Capturing GPV
through the stenosis region of interest, ROI, means that the ROI is relatively large. Therefore,
it is necessary to determine which fps is required to capture the whole ROI. The restriction
causes the velocity to increases therefore, fps needs to be greater than in the channel. For
this reason, in some cases, multiple captures at different fps were needed to ensure a reliable
measurement of the velocity through the whole stenosis area. With a greater stenosis there
is a greater difference in velocity from the main channel and in the middle of the stenosis.
It was established that the SA5 camera was the most suitable in order to capture the GPV
speckle pattern over a relatively larger area in comparison to the SA3. Both fps and shut-
ter speed were investigated to optimise the visualisation of the speckle pattern through the
microfluidic device. Once all parameters were established it is possible to take accurate mea-
surements using GPV within one plane (figure 3.1).
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Figure 3.1: A graph showing that the flow is in steady state within the 100 frames recorded.
This particular graph is for flow rate 20 µL/min and a fps of 20 000. Scale bar = 40 µm
In order to validate the selection of 100 frames, it is possible to use the approach used
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by Riccomi et al. [100]. The positions represented as p in figure 3.1 are indicated in the
velocity map plot with complimentary colours. It should also be noticed that in figure 3.1
the first 20 frames are not very steady for position 5 (P5) which is the stenosis region. This
is due to the frames per second not being high enough to capture the displacement of the
speckle pattern. As seen previously by figure 3.1. For this reason a minimum 100 frames
were used in all microfluidic experiments throughout this thesis. The reliability of the GPV
set up is displaced below in figure 3.2 the data points are taken from before the stenosis and
therefore are slightly higher than the theoretical velocity of the main channel if W = 200µm.
However, the theoretical velocity through the stenosed region has a much greater gradient
because due to the smaller channel width (w = 40µm) the velocity is more susceptible to
change considering that the velocity is proportional to the cross-sectional area of the device
according to equation 2.3.

































Figure 3.2: This is a graph to show the reliability of the GPV set up including: syringe pump
and image capture. The theoretical velocity through a W = 200µm channel is displayed by a
red dashed line and the orange dashed line is the stenosed region of 80 % with a w = 40µm.
The experimental result is presented by the circular data points.
To progress the experiment further, plasma was used to try and observe GPV. Plasma is
optically transparent and contains a high proportion of blood proteins (albumin, globulins
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and fibrinogen). It was thought that perhaps the concentration of proteins would be high
enough to refract the light similar to that seen previously in the GPV experiments. As you
can see from table 3.2, the concentration of proteins is substantially higher than that used
for GPV (0.1−0.2w/v%).
Table 3.2: A table to present proteins in blood plasma and their corresponding sizes
Protein Mw (kDa) Size (nm) Concentration(w/v %) Ref
Albumin 66.5 9 x 6 x 5 nm 3.5-5.5 [131, 132]
Globulins 93- 1193 > 10 nm 0.15-0.4 [133, 134]
Fibrinogen ≈340 rod shaped 9 x 47.5 x 6 nm 2.6-3.5 [135, 136]
Clearly another important parameter to consider is the refractive index, n. For a healthy
human the refractive index of blood plasma is n = 1.35 [137] where as the refractive index
of PS nanoparticles in suspension is n = 1.59. These parameters should have been suitable
for the capture of a speckle pattern in a microfluidic channel, however the proteins in blood
plasma are too small and the refractive index of the proteins is too similar to plasma. This
stops the speckle pattern occurring. However, if blood plasma was to be diluted it could be a
suitable alternative for GPV analysis. This would be a useful alternative for if/when cells are
added to the stenosis devices as nanoparticles are toxic to endothelial cells [138].
3.1.2 Flow through Symmetrical Channel
The symmetrical channel was used to optimise the microscope set up, various fps and shut-
ter speeds were investigated. For this 80% stenosis with w = 200µm devices was used. The
establishment of optimum conditions for the different flow rates (20−200µL/mi n) the in-
vestigation of flow around the stenosis can be carried out. The theoretical values of velocity
(calculated via equation 2.3) closely match the experimental results in the microfluidic chan-
nels. A thrombus occurs before the stenosis in murine models [139], however in arterial clot
formation it initiates after the stenosis [73]. Arterial models and venous models are not com-
parable for thrombus formation. Therefore, due to thrombosis occurring before the stenosis
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in the murine model the ROI within the microfluidic channels will be before the stenosis.
An example of a typical velocity profile map can be seen in figure 3.3 and should be noted,
what can be seen is the smallest channel (200 µm) with the largest stenosis (80 %) which is
mimicking the murine model idyllically. The diameter of a mouse IVC is 200-300 µm and
within the stenosis they restrict the vein by 80-90 %, the conditions is mimicked within the
x-y plane below in figure 3.3. In vivo the stenosis is 3D and the percentage is defined by the
diameter in which it is smaller than original diameter of the blood vessel. In the microfluidic
case, the restriction can only be applied in the x-y direction, meaning it is a 2D restriction.
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Figure 3.3: A velocity magnitude map of the 200 µm microfluidic channel with 80 % stenosis.
The flow rate here is 20 µL/min and the capture rate is 20 000 fps with 50 µsec shutter speed.
The markers seen on this velocity plot are to determine the steady state of flow over a 100
frames and the results can be seen in figure 3.1. Scale bar = 40 µm
It was determined that the optimum shutter speed was 50 µseconds to achieve the most
reliable GPV. This can be confirmed using the same steady state validation plots as seen by
100 frames. The respective graph can be seen from figure.
Obviously at these flow rates the Reynolds number, Re =0.0005 - 0.005 (using equation
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1.1 and flow rates 20−200µL/mi n) which is a laminar flow regime. Although these values
would appear low, they are well within the Re numbers for a mouse IVC [140]. According to
literature the mean velocity of blood flow through a mouse superior and inferior aorta is 18
cm/s with the hydraulic diameter, DH , of 1.09mm [140]. The dynamic viscosity of mouse
blood at sheer rate 94s−1 is 4.9 mPa s [141] and the density is 1.057 g /cm3 [142]. Using
equation 1.1 the Re = 66, however when the velocity is reduced to 3 cm/s and the viscosity is
13.4mPas at 0.7s−1 the density would remain the same and the DH would be 0.2 mm [32] the
Re number would be as low as 0.0005. Meaning that it is possible to mimic the venous system
of a mouse relatively accurately and therefore flow patterns will be relatively the same as in
vivo. The only parameter not taken into consideration which may affect the flow patterns
around the stenosis are the non-Newtonian properties of blood flow.
Before the stenosis there was no indication of any complex flow patterns occurring (e.g.
vortexes) indicating that perhaps fluid flow is not the parameter inducing thrombus forma-
tion. In fact, a strong possibility for a thrombus forming before the stenosed region is the
’bottle-neck’ effect. As the red blood cells and platelets flow through the IVC of the mouse,
when they approach the stenosis area there is a back up of blood cells and in effect will have
more cell-cell interactions which increases the likelihood of clot formation [143]. This would
not happen in arterial models as the flow has a much higher velocity resulting in the re-
circulation after the stenosis activating the platelets and causing thrombus formation[73].
This could explain why there is different thrombus compositions in the murine and in vitro
models[73].
3.1.3 Flow with the presence of a Closed Side Branch
The closed side branch aimed to represent those side branches that were ligated, there-
fore mimicking a deformity in the IVC. It is also discussed in literature that even when the
side branch is ligated, thrombus formation is affected [53]. The presence of the closed side
branch did not disrupt flow around the stenosis or the main channel itself. In larger devices
it is possible to increase the flow rate (as seen in figure 3.4). It can be seen that even with
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higher flow rates that there is no disruption to the laminar flow regime. Even at the maxi-
mum velocities at the centre of the channel equalling ≈0.08 m/s meaning that the Re = 0.013
when following equation 1.1.
Figure 3.4: A velocity magnitude map of the 500 µm microfluidic channel with 80 % stenosis.
The flow rate here is 40 µL/min and the capture rate is 10 000 fps with 50 µsec shutter speed.
Scale bar = 250 µm
3.1.4 Flow with the presence of a Side Branch
The presence of a side branch did not seem to affect the flow regime through the device.
It was suggested in literature that the presence of a side branch would modify thrombus
formation. However, there is a distinct lack of understanding of fluid dynamics within mouse
veins. For this reason both the usual polystyrene, PS, suspension and whole blood studies
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were investigated. It is of general opinion that the side branch interferes with flow and can
therefore initiate or alter thrombus growth, from these findings it was hypothesised that this
was due to a recirculation at the top of the side branch, just before the stenosis. From a
chemical engineering perspective of fluid flow, this would not be the case as the Re number
of blood flow through the IVC of a mouse would be less than 2000 and therefore within the
laminar regime. This is what was witnessed within the experiments carried out.
Figure 3.5: A velocity magnitude map of the 500 µm microfluidic channel with 80 % stenosis.
The flow rates in the side branch and main channel are equal of 100 µL/min. Scale bar = 250
µm
This geometry has been explored in greater detail in the next chapter. To further prove
the laminar conditions in the microfluidic devices whole blood was used.
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Whole Blood Work
Using the side branch geometries, whole blood was investigated to determine how the loca-
tion of the side branch with maximum stenosis (80%) would effect the blood flow. The aim
was to better mimic the in vivo condition using whole blood. The blood was collected and
used within 3 hours and was treated with EDTA to prevent it from clotting within the eppen-
dorf. In order to visualise flow whole blood from a healthy subject was taken and pumped
through the main channel along with PBS buffer. From figure 3.6 it is possible to see that
even with independent flow rates of the side branch and the main channel there is no mix-
ing of any kind when the side branch has a lower flow rate than the main channel. When
the side branch is 10 times greater than the flow rate in the main channel there is recircu-
lation and back flow within the channel. However, it should be noted and can be seen that
the use of whole blood makes it very difficult to visualise specific flow patterns as mentioned
previously in the introduction.
Figure 3.6: Bright-field microscopy images of blood flow through the 200 µm microfluidic
channel with 70 % stenosis with side branch positioned 600 µm away from the stenosis.
After multiple parameters were explored, it was concluded that perhaps mimicking the
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murine model is not the most efficient way to investigate how geometrical parameters will
influence the flow patterns and in turn the initiation of thrombus formation. To visualise the
video’s capturing laminar flow through the side branch geometries proving the reproducibil-
ity and validity of these findings, please refer to video tape which is available upon request.
The Re number of the whole blood in the side branch at 100 µL/min is 57 assuming that the
density of blood is 1060 kg /m3 and the dynamic viscosity is 3 times that of water [144]. Of
course, this is variable depending on person-to-person.
3.1.5 3D Cylindrical Design
As mentioned previously in section 2.2.1 there were complications when it came to fabri-
cating a full cylindrical device and for this reason the 3D flow analysis was carried out on
half-cylindrical device (figure 3.7). Consequently advancing from the simple square cross
sectional devices allowing for the investigate the influence of curvature with in the z-plane
(as well as the x-direction) has on flow.
Figure 3.7: A CAD image showing final geometry for the 3D printed stenosis device highlight-
ing a particular region of interest for the investigation of flow around the stenosed region
The 3D devices with cylindrical geometry present intrinsic optical aberration when ob-
served using the microscope as the refractive index, n, of the water solution of polystyrene
nanoparticles (n = 1.33) is different from the one of PDMS (n = 1.41). There are many ways to
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match the refractive index of PDMS, one was to add sucrose solution to the water (48% w/v),
when the refractive index matched that of PDMS. The nanoparticles have an electrostatic
charge of which is slightly negative due to the carboxyl groups on the surface. However,
due to the electrostatic shielding induced by the sucrose the nanoparticles severely aggre-
gated even with the addition of surfactants (tween80, tween40 and sodium dodecyl sulphate
(SDS)). The presence of large aggregates was problematic for GPV as they are within the
diffraction limit of the microscope and will be resolved in a larger volume compared to the
speckle pattern which is confined to a specific plane [84]. After exhausting this approach an
alternative was found; by using a mixture of water and glycerol (58% v/v), and index match
was achieved. As the mixture water/glycerol does not add electrolytes, aggregation will not
happen, however the viscosity of solution will be altered to six times that of water. This also
has a secondary advantage as it is closer to the viscosity of blood and consequently increases
the Re number more representative of the human condition.
Once the refractive index is matched it was then possible to analyse the velocity profile at
various points across the z-plane [84]. This is because δz ≈ λ/(N Ac )2 where δz is the longi-
tudinal speckle characteristic size µm and λ is the wave length of light (nm). By altering the
aperture it is possible to see the ‘speckle’ pattern within tens of microns resolution [84]. The
results show a parabolic profile across the z-plane as well as well as the x-plane indicating
that the addition of a curved surface to the stenosis geometry has no effect. Thus indicating
that flow through the micro and milli - fluidic devices is purely laminar within the experi-










































































The velocity profiles in the z direction show that the flow is laminar. This is a half-
cylindrical device so the tapering off of the velocity in plots A, C, D-E make sense as the
slower velocities are closer to the channel wall. In particular velocity profiles D-E are enter-
ing the stenosis region meaning again that the z-position is closer to the vessel wall in com-
parison to previous z-positions. As for positions G-I, the velocity profiles are not at a high
enough resolution to capture the velocity profile. Remember the stenosed region is 0.15 mm
and this is not accounted for within this figure. This could be over come by using smaller
step sizes to enable quantification of the parabolic flow in the z-direction through the steno-
sis region. However, this is not possible within the set up available. The stage control on
the microscope is able to estimate the position within the z-direction, however this is not as
accurate to be able to account for reliable smaller step sizes. However, it can be seen from
position B, that parabolic flow is occurring in the z-direction as well as the x direction which
is to be expected with laminar flow conditions. For this reason it can be assumed that even
with the lack of whole blood experiments, that the flow patterns prior the stenosis would be
translational according to Re number. It would also be apparent that the Newtonian influ-
ence of the fluid would be most prominent after the stenosis due to the differences in shear,
the region not of interest within this model.
In addition to investigating the influence of curvature on flow patterns around the steno-
sis, the use of platelet rich plasma was also explored. It would be safe to state that there was
no flow patterns prior the stenosis which would be of interest when trying to understand
how thrombus formation occurs within murine stenosis model. For this reason, it would be
relevant but bold to state that perhaps the induced stenosis model may not be a relevant for
modelling DVT. There is a clear lack of acknowledgement of ’bottle neck effect’ and how this
could encourage clot formation within the stenosis model. Yet it is well known that increased
cell-to-cell interactions would increase clot formation. The lack of coupling between these
acclaimed statements suggests a severe underestimation between the connection of physics
and biology when it comes to investigating DVT.
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3.1.6 Simulation
The simulations were used to confirm the experimental findings, including that there is no
’turbulent’ flow at the neck of the stenosis as is suggested in literature [33].
2D Simulations
. The use of open source software enhances capabilities of the user as well as being able
to control the conditions of the FE simulation. This was certainly the case when it came to
acquiring the following simulations. It is to be expected the flow through all devices is to
be laminar, there for a parabolic regime is to occur. This can be seen in all of the following
simulations. These 2D simulations were calculated using COMSOL multiphysics software.
As you can see from figure 3.9 the experimental and computation results are complimentary
to one and other. This was the same for the other simulations, which can be found in the
appendix A.
Figure 3.9: A is the simulation result calculated using COMSOL compared with B which is
the experimental result of the closed side branch 500 µm channel with 80% stenosis. Scale
bar A = 500 µm. Scale bar B = 250 µm
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3D Simulations
The simulation results of the half-cylinder, were problematic. The first attempt used a rel-
atively fine mesh with no refinement throughout the geometry. The velocity for this initial
geometry was set to 0.1 m/s, which is on the higher end of the experimental velocities. It
can be seen from figure 3.10 that there is an obvious mistake within the simulation. This is
because we expect to see a higher velocity through the stenosed region, however this is not
the case. It was suspected that the reason for this irregularity was due to an insufficient mesh
density through the stenosed region. In order to over come this issue without increasing the
converging time localised mesh refinement was carried out in order to achieve a more re-
alistic parabolic flow condition, as experienced in the experimental results. The scale bar
presented here is wrong, as the stenosed region of the geometry has not got an accurate ve-
locity profile. Even after mesh refinement around the stenosed region there was still this
error occurring which is not seen in the 2D COMSOL simulations carried out early on.
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Figure 3.10: This was the first converging result using Elmer FEM software. Firstly A shows
the mesh created in gmsh followed by the convergence history in plot which took 8.39 sec-
onds B) and C) is the velocity profile result presented using ParaView
For reasons aforementioned the results in figure 3.10 are therefore deemed unreliable
and not sufficient enough to validate experimental findings. The main reason for this error,
is the need to investigate further mesh refinement around the stenosis region, especially
within the volume. However, with the use of a full cylinder it was possible to run simulations
which replicated the parabolic flow seen in previous experiments (see figure 3.11.
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Figure 3.11: The velocity magnitude profiles of the cylindrical device with inlet velocity set
to 0.13 m/s (near the maximum seen in microfluidic devices previously). The plot indicates
the strong parabolic flow through the D=300 µm stenosis of the full cylindrical device.
The fact that the parabolic flow is occurring even at high velocities indicates that flow
within a murine model is definitely going to be laminar and not exceed Re >2000 (see figure
3.11. The mesh for this particular result was created using Elmer automatically by importing
the 3D structure via .iges file. This did not work for the 2D structures in previous simulations.
There is no evidence of regions where recirculation would occur prior to stenosis and there-
fore must be due to the accumulation of platelets and red blood cells creating a ’plug’, i.e.
thrombus. A theory to why thrombosis occurs in this way could also be explained using fluid
dynamics. It is known that larger particles are pushed toward the boundary in parabolic flow
conditions. In this case it would be red blood cells. If the red blood cells were are at a greater
concentration at the boundary when they reach the stenosis they are going to be pushed to-
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gether forming a nucleation point. This nucleation point would instigate to accumulation of
platelets, which are travelling faster within the centre of the vessel and result in coming to
a drastic slow down/halt. This would then initiate the formation of a thrombus and explain
why the venous thrombosis has an alternate physiology to arterial thrombosis and why the
thrombus does not form on a vessel wall. The parabolic flow forces larger particles (red blood
cells) to the vessel walls. This would cause a nucleation point for the platelets encouraging
aggregations.
Sub sections 3.1.2 to 3.1.4 have been successful at determining:
• The optimum optical set up in order to capture GPV for accurate velocity profiling
• Determining that it is possible to use 200 µm microfluidic channels with 80 % stenosis
and still be able to track velocity profiles through the stenosed region
• Proof, although already know, all flow is laminar within these dimensions which is sim-
ilar to in vivo murine conditions [32].
• The side branch does not disrupt flow around the stenosis meaning further investiga-
tion is needed to understand how side branches influence thrombus formation and
growth.
It should also be noted that these results can be advanced further, with more advanced blood
investigations including using fluorescently labelled platelets to determine where they ag-




After presenting the fact that stenosis does not seem to alter flow patterns or cause stagnant
regions the questions arises, "what about the rest of the mouse?". The cardiovascular net-
work is a complex pipework system with multiple routes to and from the heart. If a mouse
has the IVC ligated (100% restriction), it will continue to live normally, therefore there must
be an alternate route back to the heart. With this in mind it is possible that when the stenosis
is within a certain distance from a side branch it will cause a pressure drop which will induce
the blood to bypass the stenosis preventing thrombosis to occur. This is what happens in
industrial pipe lines if there is a blockage, an alternative route is found or the plant stops all
together due to a pressure increase/drop in a particular section. Valves are put in place in or-
der to prevent blockages or encourage a diverted route [145]. It is reported that the position
of side branches and back branches correlate with the size and occurrence of a thrombus
within the IVC of a mouse [33]. A simplistic approach has been used to study a bypass de-
sign of micro-vasculature. A similar approach has been used to investigate a pressure drop
in microvasculature [146]. It was found that red blood cells travel through the main chan-
nel and stenosis in laminar flow conditions, as to be expected with microfluidic dimensions.
They compared water, diluted red blood cell suspension and a artificial blood solution (10%
glycerine) and found that there was a linear relationship between pressure drop and the ve-
locity of side branch through a 40% stenosed channel [146]. Within this chapter a wide range
of controlled conditions are investigated, including: position of side branch, flow rates and
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degree of stenosis.
The following results provide evidence that a bypass can occur depending on a pressure
drop. Evidence will also be presented indicating how the position and width of the side
branch can influence stagnant regions within the channel. These stagnant regions high-
light regions where thrombosis is likely to occur. As emphasised in the introduction both
these geometrical parameters are pivotal for thrombus formation and growth in vivo [33, 10].
There are no reports of valves in the murine model, suggesting a bypass is more plausible.
This chapter therefore aims to provide evidence that: 1) a bypass is possible and 2) which
parameters are most important to consider.
4.1 Results and Discussion
The complexity of the device meant there was a wide range of velocities through the different
regions. As mentioned previously in the introduction, one of limitations of the camera is the
ability to track the velocity. It is important to get the frame rate right in order to measure the
speckle pattern displacement. Therefore, when the flow appeared stagnant, a lower frame
rate was selected to ensure this was an accurate result. Throughout this chapter 4 regions of
the bypass device will be referred to: the main channel, bypass and side branch, all of which
are labelled in figure 4.1. In the plots there will be reference to main channel before the side
branch (MCB4), main channel after side branch (MC Aft SB), main channel after the stenosis
(MC AftSten), side branch (SB) and bypass (BP). To reiterate the three positions of the side
branch: position A = 1600 µm, position B = 600 µm and position C = 300 µm away from the
side branch (as stated in section 2.1.2).
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Figure 4.1: A CAD drawing of the bypass geometry with the three different positions of the W
= 100 µm side branch. Blue arrows indicate flow from the syringe pumps
The first experiments are conducted using a syringe pump to control the velocities within
the two channels. If the velocity in the side branch is lower than the main channel it is hy-
pothesised that a bypass will occur. Depending on whether there is a full or partial bypass
will dictate the velocity after the side branch (but before the stenosis). The use of a syringe
pump will mean that the velocity in the side branch will be influenced by the width, the
smaller the channel the higher the velocity. This is basic fluid dynamics. The pressure with
in the channel is also linked to the velocity and width, therefore by altering the width of the
channel will influence the pressure within the system. For the latter experiments, a pressure
controller is used to control the pressure drop directly.
4.1.1 Influence of Position of Side Branch
As fore mentioned in the methods section 2.1.2, three positions were explored: 1600 µm, 600
µm and 300 µm away from the 80 % stenosis. The reason for focusing on 80 % stenosis is
because this is the closest to in vivo case [32]. With increased stenosis there is an increased
likelihood of a thrombus forming [10], however the presence of a side branch close to the
stenosis reduces the occurrence of a thrombus [33]. By exploring different flow conditions
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in both the side branch and the main channel it will be possible to discover which position
of side branch is most probable of causing a bypass. In order to determine which flow rate
is the most influential on causing a bypass to occur the flow rate (controlled by the syringe
pump) in the side branch are altered 1-10 µL/min whilst the flow rate through the main
channel is maintained at 10 µL/min as seen in figure 4.2 A and B. This is then switched in
figure 4.2 so that the main channel is changing flow rates from 1-10 µL/min and the side
branch is kept at a constant flow rate of 10 µL/min. The velocities can then be measured
using GPV throughout the different regions highlighted in both figure 4.1 and 4.2. It should
be noted that despite one of the channels having a constant flow rate at the inlet, all regions
are effected by the changing flow rate at the other inlet. A greater overall influence on all
regions seems to be more prevalent when the main channel flow rate is changing.
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Figure 4.2: Four graphs demonstrating how the difference in side branch position directs
flow through the bypass geometry. Regions highlighted about the graphs are selected and the
mean velocity has been plotted. A and B shows the velocities in the different regions when
the side branch flow rate is changed from 1-10 µL/min (x axis) and the main channel flow
rate is set to 10 µL/min. C and D show the alternate condition, the main channel changes
flow rate from 1-10 µL/min and the side branch flow rate is maintained at 10 µL/min. A and
C are plots for side branch positioned 600µm away from the stenosis and plots B and D show
velocity plots for side branch positioned 300 µm away from the stenosis. Both side branches
have a WSB = 200µm.
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Figure 4.2 A indicates that there is a full bypass occurring as the fluid is stagnant up until
9 µL/min. The main channel is maintaining a constant flow rate of 10 µL/min the velocity of
the side branch is gradually increasing up until the flow rate in the side branch is 9 µL/min.
At this point it seems like there is an equilibrium of pressure as the velocities all balanced
out at a constant. By increasing the flow rate in the main channel the behaviour of the flow
is the inverse. Instead of the bypass rapidly decreasing, the velocity rapidly increases when
flow rate 7 µL/min and a full bypass is initiated as flow is 0 m/s at 8 µL/min. Flow has been
redirected from the main channel before the side branch down through the bypass. The
pressure through the bypass (w = 100µm) region is greater than in the main channel which
will redirect the flow. As for position C (figure 4.2, B and C), there appears to be no bypass
across all conditions. There is a constant stagnant region in the side branch when the side
branch flow rate is changing, indicating that the velocities in the main channel and bypass
regions are roughly the same, which can be seen in figure 4.2 B.
It should be noted that even if a full bypass does not always occur, there would be less
fluid going towards the stenosis. In these cases 200 nm particles were used, which are sta-
ble in suspension. When there is a partial bypass, there is less particle suspension flowing
towards the stenosis. Less particles means a reduced particle-particle interaction. Although
no accumulation would be witnessed due to the size and concentration of the 200 µm parti-
cles, in an in vivo case, blood cells are much larger at a higher concentration. This means that
if a full bypass is occuring there is a stagnant region before the stenosis. Stasis in vivo means
there is an increased cell-cell interaction and blood is more likely to clot [15]. Alternatively
if there is a partial bypass in vivo a thrombus is less likely to occur due to the reduced blood
flow towards the stenosis. This would mean a reduced accumulation of cells at the stenosis.
There would be constant flow through all the blood vessels. If the side branch is stagnant
there is still fluid flowing around the stenosis in the smaller channels. If the main channel
velocity is slower, then there is a stagnant region between the side branch and the stenosis.
Stasis encourages clot formation which could be the reason why large, reproducible clots
form when the main channel has a lowered velocity.
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Finally, with the side branch least expected to have a bypass, position A, the results were
as predicted [33]. Due to the stenosis being so far away, two videos had to be captured in
order obtain the velocity profile throughout all the specified regions. In previous examples a
bypass full/partial was observed when the flow rate in the side branch was 1 µL/min and 10
µL/min in the main channel. For position A this is not the case. The side branch, however
was stagnant in these conditions. This is the first instance where the side branch remains
stagnant whilst the bypass and main channel has flow. Raising the idea that, although it was
originally thought that the thrombus initiates and propagates in the IVC, main channel in
our case, it could start in the side branch and detach to move into the main channel. There
are no studies to suggest this is not a possibility therefore more research would need to be
carried. Inversely, when the flow rates are switched the all the regions have flow as seen in
figure 4.3.
Figure 4.3: Velocity magnitude map of bypass design, positioned 1600 µm away from the
stenosis with WSB = 100µL/mi n
To conclude whether position of a side branch encourages the presence of a stagnant
region, the answer is yes. Stasis before the stenosis is probably the region for a thrombus
forming, not a recirculation of flow as suspected in literature [33]. Stagnant regions have
84
been proven to cause thrombosis within venous conditions [25]. It should be emphasised
that 300 µm is a very short distance and when carrying out the operative procedure on the
mouse would be very difficult to avoid damaging the vessel wall, where as 600 and 1600 µm
are a lot more manageable. If damage did occur to the IVC of the mouse, the clot formation
would occur similarly to that seen in arterial clot formation, exposure of the extracellular
matrix [147].
4.1.2 Influence of Side Branch Width
The width of a side branch is important to whether a bypass with occur as although the flow
rates applied from the syringe pump are the same the velocity is determined by the channel
dimensions (equation 2.3). Previously, the results for side branch width 200 µm has been
presented in figure 4.2. Throughout this section multiple plots and velocity profiles will be
compared to aid in the determination of which factors are most important in creating a stag-
nant region within the channel. The data shown in figure 4.4 is particularly interesting be-
cause, when the side branch flow rate is lower than 9 µL/min there is no flow through the
main channel and a complete bypass is occurring. In comparison to figure 4.2 B, the bypass
does not transpire, the reason for this is the fact that the side branch is the same width of the
main channel. When the side branch is 100 µm there is a full bypass, meaning that there is a
stagnant region after the side branch but before the stenosis is where the thrombus is formed
in the murine model [148]. The flow in the main channel before stenosis has the same be-
haviour as seen in figure 4.2 A and the bypass region is gradually increasing in velocity up
until a rapid drop at the same point where the bypass stops.
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Figure 4.4: Data showing how the width of the side branch means that there is a stagnant
region up until 9 µL/min. Degree of stenosis = 80 %, width of channel = 100 µm position C.
Red arrows indicates the direction of flow.
The velocity profiles seen in figure 4.4 are the mean velocity profiles of the standard 100
frames. The orange arrows should be ignored as they are not representative of the true data
seen in figure 4.4 A and B after the side branch. Even when using lower flow rates the disorder
in this region suggests that there is no flow within this region after the side branch, before
and after the stenosis. The flow is being redirected down the side branch into the bypass
region. Furthermore, when the main channel is changing, the graph looks similar to the plot
seen in figure 4.2 D. The side branch suddenly tails off at 5 µL/min when the side branch
is 100 µm in figure 4.5 where as in figure 4.2 drops off at 4 µL/min before plateauing at 6
µL/min. Even when the side branch velocity starts to reduce the bypass region maintains a
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steady increase in velocity. The similarity between these plots is probably due to the position
of the side branch being the same.
Figure 4.5: Data showing the how the velocity in the four regions changes as the side branch
is kept at 10 µL/min and main channel increases, as seen by the red line. The width of the
side branch is 100 µm
4.1.3 Influence of Degree of Stenosis
With a greater stenosis there is an increased pressure drop which would redirect the flow
around the bypass instead of through the stenosis.
There are two ways to measure how the amount of stenosis influences the direction of
flow within the bypass device. By using 80-50 % static stenosis it is possible to investigate the
influence of flow as seen before in the previous sections. The second is by using a dynamic
pump device as described in methods section 2.2.2. There are two channels with no outlet
which were filled with ink (as seen previously in figure 2.14). A liquid need to be added into
the pump geometries because if they are filled with air gas is pushed through the PDMS gap
between the channel and the pump forcing air bubbles into the channel. Using the pressure
controller to apply pressures from 0 - 2000 mBar it is possible to control the restriction in
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the y direction by pushing the channel walls from either side causing a restriction. With in-
creased pressure there is an increased restriction to the channel, similar to that seen in the
stenosis model. Three devices were tried, the best for applying a stenosis was the geome-
try with the smaller pump design (L=500 µm). Therefore all the results collected from the
pressure induced bypass is collected using this geometry, figure 4.6
Figure 4.6: The CAD drawing of the devices used to apply a controlled stenosis in the main
channel.
Flow rate Induced Bypass
All the data presented previously has an 80 % stenosis and will therefore not be presented
again but will be discussed in this section. The 50 % stenosis has flow characteristics are
more predictable than the previous results with the largest restriction of 80 %. In the case of
50 % stenosis the region before the side branch the velocity remains relatively stable, along
with a slight increase in the velocity after the side branch and a rapid increase in side branch
and bypass velocities (seen in figure 4.7). Most importantly, no bypass occurred in this sce-
nario indicating that the amount of stenosis is crucial for a bypass. This is to be expected as it
was also determined in the pig model that with a greater restriction there was a larger throm-
bus formed [10]. It is quite likely this is the same as for the murine model as the restriction
applied is 80-90 % [32]. As for when the main channel is changing flow rate, the situation
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is very different. There is a sudden change in flow in the side branch at 5 µL/min, half the
flow rate in the side branch (10 µL/min). As mentioned previously the flow rate applied to
the side branch has been constant throughout all the experiments, the degree of stenosis
will induce an increased pressure through the stenosed region. This increase pressure in the
stenosis will effect the velocity in the main channel, especially between the side branch and
stenosis. This effect would be more prominent when the side branch is closer to the steno-
sis. In this case the side branch is also half the width of the main channel. Immediately after
5 µL/min the flow returns back to the side branch region of the device. It would seem that
actually if the stenosis is at 50 % it has no effect on the flow regardless of the different flow
rates through the side branch and main channel.
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Figure 4.7: Plots for 50% stenosis and 100 µm side branch. A) plots the velocity for increasing
side branch flow rate, and B) is for increasing main channel flow rate
With a 50% stenosis it was expected that a bypass would occur according to literature
[146]. In the study from Hu et al., it was found that a pressure drop occurred with a stenosis
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of 40 % and only from one side making it more of a step geometry. The edges where also 90◦
which is not typical of venous networks and the velocity was considerably lower than would
be expected in vivo. In this model the edges are rounded as they would be in vivo, as well as
having a less harsh angle of 45 ◦. Again, it is not known to where the thrombus is initiated in
vivo.
At this point it would be right to assume that the greatest influence on whether a full
bypass will occur is the flow rate of the side branch and the 80 % stenosis. In two cases:
1. Side branch position B, side branch width = 200 µm, side branch flow rate changing,
stenosis = 80%
2. Side branch position C, side branch width = 100 µm, side branch flow rate changing,
stenosis = 80%
3. Side branch position B, side branch width = 200 µm, main channel flow rate changing,
stenosis = 80 %
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Pressure Induced Bypass
Figure 4.8: An indication of how the velocity was measured using GPV, with A) showing the
bright field image of the device including the pump mechanisms, B) the GPV indicating
the lack of signal within the pump systems and finally C) showing the velocity magnitude
through the main channel and side branch.
As aforementioned the degree of stenosis influences the pressure drop within a vessel. The
following results explore how the influence of a stenosis and velocity of the fluid impact the
redirection of flow. It was established that the primary driving force that encourages a bypass
to occur is a combination of the two parameters: stenosis and velocity. Therefore, in these
next results smaller increments of stenosis are going to be investigated. Instead of using 50
and 80 %, it is possible to implement pumps on either side of the channel as described in
methods section 2.2.2 to employ ≈ 10 µm increments of stenosis as seen in figure 4.9. Using
smaller increments will allow for the determination of how restricted a murine blood vessel
has to be in order to cause a bypass to occur. Figure 4.9 was collected by applying pressure
to the pump geometries (which were filled with ink) from 0-2000 mBar. As the pressure is in-
creased it causes the pump geometry to squash the main channel, thus causing a restriction.
The degree of stenosis can be measured by considering the width of the main channel as be-
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ing 100 % (W = 300 µm). Then at the different pressure the restricted part of the channel can
be measured and divided by the original width and multiplied by 100 to get the percentage
at which the restriction has implemented.
Figure 4.9: Linear correlation between increased pressure in the pump system and the degree
of stenosis. Degree of stenosis is the percentage at change between the straight channel (300
µ) and the restriction induced by the external pumps. Error bars are the mean standard
deviation of three different experiments using the pumps to restrict the channel. R2 value
= 0.95.
At maximum mBar the pressure controller could operate at (2 Bar) the amount of stenosis
was only ≈50% (figure 4.9). As you can see from figure 4.10 the flow is not influenced with
the increased stenosis. This is probably due to the stiffness of the PDMS. The stiffness of the
PDMS can be altered by changing the ratio of the PDMS and curing agent [118]. The material
properties of the PDMS changes drastically when the PDMS component is increased and the
curing agent is kept the same, this is due to the reduced crosslinking between the polymers
meaning the material is more flexible [118].
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Figure 4.10: Three images indicating that even with 50 % stenosis no bypass occurs.
Two different sized particles were used through out the pressure controlled experiments
200 nm for GPV analysis and 3µm particles to aid with visualisation of a potential full/partial
bypass. The particles used to characterise the flow within the experimental parameters:
main channel 70 mBar and side branch 40 mBar were 200 nm. However, with the use of
larger particles it is possible to visualise a bypass more prominently (see figure 4.10). The
bypass in 40/70 mBar case is partial and occurs at the maximum stenosis capable within this
device, ≈50 %. Increased flexibility of the PDMS will allow for a larger stenosis. It would also
aid in giving a higher resolution of data as it would be possible to use smaller increments.
The large particles were generally added into the main channel only so it would be clear that
a bypass would occur. When there is no stenosis, there is no bypass and the side branch is
stagnant. Seen from previous experiments, the degree of stenosis is crucial for a bypass to
happen. Therefore, if the stenosis was closer to the desired 80% a bypass would be more
likely to occur according to previous results. This could also be more representative of the
murine case in vivo.
As it was found that when the side branch flow uses lower flow rates, in order to recreate
this situation and to encourage a bypass to occur the following parameters were used: the
side branch pressure is 10 mBar and the main channel is 80 mBar. Large particles were used
and it was found that the fluid flows backwards down the side branch. There was no differ-
ence in flow even when a stenosis was applied. Likewise if the pressure in the main channel
is 10 mBar and the side branch is increased to 50 mBar there is back flow down the main
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channel.
Another interesting occurrence is the build up of nanoparticles seen on the corner be-
tween the side branch and the main channel. In literature this has been highlighted to be a
phenomenon of shear [149]. It has been suggested that the angle of the side branch can en-
courage/discourage platelet activation and ultimately aggregation. The fact accumulation
still occurs without the presence of biological factors (proteins, cell signalling) suggests that
the aggregation is driven by the physics of the fluid flow. This suggests that the thrombus
could form in the side branch and get trapped and propagate in the main channel, or IVC in
vivo.
All scenario’s demonstrated that although the different geometric influences flow the
main contribution to a full bypass arising was having a lower flow rate in the side branch.
However, it is definitely a contribution of flow conditions and geometric parameters cause
the full bypass as it does not occur in all instances. Another region which appears to cause
particle accumulation and can be stagnant is the side branch. The potential of the thrombus
being initiated somewhere else and getting trapped at the stenosis does not seem to have




The valve model allows for a more in vivo relevant understanding of deep vein thrombosis.
By advancing from the stenosis model it is possible to observe complex flow patterns around
flexible valves. As highlighted previously there are many drawbacks with the stenosis model
ia that enforcing a restriction forces thrombosis to occur. The restriction increases the num-
ber of cell-to-cell interactions increasing the likelihood of thrombus formation, thus making
it a less desirable approach for investigating the physical mechanisms behind DVT. By in-
troducing passive valves which open and close as a result of flow does not force thrombosis
to occur, as this is the mechanism at which venous valves function in vivo. Therefore, this
novel combination of micro-fabrication methods and flow visualisation allow for the inves-
tigation of how flow patterns can change around passive valves depending on the stiffness
and geometry [122]. Stiffness of valves could be an initiator for thrombus formation and is
thoroughly investigated through out this chapter.
5.1 Results and Discussion
5.1.1 Successful fabrication of flexible Valves
The in situ fabrication of valves had to be standardised to ensure the reproducibility of physi-
cal and geometric properties. Initially there were minor complications following the method
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stated in literature[120], this was because in order to get the flexible valve the base of the
microfluidic device had to be spin coated with PDMS. This is because PEGDA does not cure
in the presence of oxygen. By spin coating the glass slide with PEGDA it allows oxygen to
permeate into the channel, thus allowing for a small gap between the top and bottom of the
valve in order to allow it to move when flow is added. However, the spin coating process was
consistent, there was slight variability with the PDMS layer on the glass slide. This was prob-
ably caused by the varying temperature in the laboratory altering the viscosity of the PDMS
as increased heat will decrease the viscosity resulting in a thinner layer of PDMS on the glass
slide. It was found that in order to remain constant throughout the methodology, the projec-
tion of the valve needed to be aligned with the bottom of the channel. This approach worked
for all devices.
It was evident early on that the anchor geometry was substantially better than the pil-
lared device at securing the PEGDA hydrogel in place (geometries are shown in section 2.1.3,
figure 2.5). For this reason the anchor geometry will be used for future experiments. Another
way to increase the stability of the anchored valve is to double expose the anchor section of
the valve to increase the stiffness of the hydrogel thus increasing the stability of the valve.
Even with low concentrations of PEGDA and PI the valves rarely detached from their an-
chored positions. The use of PEGDA is important as it is biocompatible, it has been used in
many tissue engineering and biomedical applications [150, 151] including specifically tissue
engineered heart valves [152]. Biocompatibility is important for the prospective future in
vitro developments.
Once the valves are fabricated it was then possible to characterise them in situ. In order
to do this water was pumped through the device at a constant flow rate causing the valves
to open. With increased flow rate there is increased deflection of the valve. Using small
deflection it is then possible to calculate the Young’s modulus using equation 2.1. It was
hypothesised the valve properties will influence the flow and could lead to a better under-
standing of how thrombus formation occurs within the deep veins. In order to investigate
this thoroughly two flow conditions were carried out:
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1. Continuous Flow = To characterise the simple valve and look at flow patterns through
and around the leaflet valves
2. Pulsed Flow = To look at complex flow patterns (forward and back flow) as well as par-
ticle accumulation
Both these conditions are discussed in great detail within this chapter. Obviously pulsed
flow is more comparable with DVT as the skeletal muscle pumps push blood back to the
heart in a pulsed manner. The pulse is not going to be as regular as the cardiac muscle and is
dependent on the mobility of the person. However, it should be highlighted that DVT is more
likely to occur in immobile patients. Immobility means that the muscle pumps may not
be working as well as they should to pump the blood back to the heart and that the valves
will not be opening and closing in the same way as they should. In fact the valves could
be partially open thus causing a slow but continuous flow through the valves. Therefore, a
continuous flow regime is also explored.
5.2 Characterisation of Valve Stiffness
In order to characterise the valve stiffness, the straight valve, may also be referred to as simple
geometry, was used and the deflection was measured as in figure 5.1, similar to Wexler et al.
In this case, however, there are two structures within the channel compared to the solitary
hydrogel valve in Wexler’s methodology. However, due to laminar flow the effect of two valves
within in the microfluidic channel should have little effect on the calculation of the Young’s
modulus due to the Poiseuille flow giving a symmetric force on each of the valves. For this
calculation to be reliable, h needs to be greater than the width of the base of the valve as
stated in the Wexler et al., [122]. The dimensions of the straight valve has a base of 25.5
±1.6µm and a general height of 121.75 ±3.6µm, which is roughly the same as Wexler et al as
there are two valves within the channel h is slightly shorter.
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Figure 5.1: A simple schematic illustrating how the deflection was measured in the simple
valves. The red arrows represent flow.
5.2.1 Varying concentration of Photo-initiator
It was found that with concentrations of PI (2, 4, 6, 8 % v/v/) the minimum exposure time
varied. Exposure time is to be expected to vary as the PI will degrade over time and because
only a small amount was being used (2-8 µL) at a time the volume of PI remains high yet the
quality decreases. The stiffness also increased with increasing concentration of PI, again, this
is to be expected as with increased concentration of PI there will be an increased number of
cross links between the PEGDA and PI [153].
It has already been established in previous research that concentrations of PI alter the
stiffness of valves in confinement. For this reason the changing of PI was used as a proof of
principle and does not require extensive research experimentally as this has been carried out
by Wexler et al. The increased concentration of PI will increase the amount of cross-linking
between the PEGDA polymers making the structure, in this case a valve, stiffer and ultimately
giving it a higher Young’s Modulus, E. E can be calculated from the deflection of the simple
valve using equation 1.2 and is shown in section 5.2.3.
In figure 5.2 the concentration of PI influences the amount of deflection. With greater
deflection, there is more flexibility within the valve, thus indicating a less stiff material. The
amount of deflection can then aid in the calculation of the Young’s modulus, E, as seen in
equation 2.1. To apply a curve of best fit to the graphs Matlab Curve Fitting Toolbox was
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used to employ a power 2 curve with the equation f (x) = a∗xb +c for each concentration of
PI the following coefficients were used (5.1).
Figure 5.2: A graph to present how the concentration of PI alters the amount of deflection
depending on concentration of PI. The lines are fitted via the following equation f (x) = a ∗
xb + c.
Table 5.1: Coefficients used in the power 2 fitting in 5.2
PI (% v/v) a b c
8 -269.1 -0.1245 215.2
6 23.95 0.2922 -26.95
4 162.4 0.09651 -174.3
5.2.2 Varying exposure time
The minimum exposure time required to cross link the hydrogel structures is independent
to the concentration of PEGDA and PI. It is possible to use 300 ms for 4 % PI with all the
concentrations of PEGDA (30-100 %), which is also consistent with literature findings[122].
During the fabrication process it was clear to determine when over exposure had occurred.
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Due to the nature of the experimental set up and use of acetate sheet photo-mask, there is
the possibility that light can ’bleed’ through the mask causing a skirt-like polymerisation to
occur around the geometry (see figure 5.3).
Figure 5.3: A bright field image of the simple valve with the ’skirt’ highlighted in pink reducing
with shorter exposure times.
In order to prevent over exposure it is possible to manipulate the light intensity and ex-
posure time. In all cases minimum exposure time was used, and to establish this multiple
exposures was systematically worked through until the valve geometry was not polymerised.
Another factor to consider is that during storage the PI degrades over time which may mean
that a higher exposure time is required in order to polymerise the PEGDA. Once valves were
fabricated it is possible to briefly investigate how exposure time influenced deflection of the
valve and in turn, E. It should also be noted that valves were fabricated and used the follow-
ing day.
It was found that the exposure time increased the stiffness of the valve, which is sup-
ported by that seen in the study by Wexler et al., confirming that the procedure is consistent
with literature. The graph shows at concentration 40 % (v/v) PEGDA and PI 4 % v/v at and
different exposure times, 300 and 325 ms (figure 5.4 and coefficients for the fitting are pre-
sented in table 5.2).
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Figure 5.4: A graph showing how exposure time influences the degree of deflection within
the microfluidic device. Red points are for 300 ms exposure and blue is for 325 ms exposure
Table 5.2: Coefficients used in power 2 fitting for figure 5.4
As exposure time has been sufficiently researched in literature and the results were con-
sistent with previous studies, it seemed appropriate to move onto varying concentrations of
PEGDA, an area of research that is not yet been explored in a microfluidic environment.
5.2.3 Varying concentration of PEGDA
Exposure time and PI have been investigated previously by Wexler et al. [122]. It would seem
that no one has used this technique to determine how concentrations of PEGDA influence
the Young’s modulus. It has previously been found in macro environments that PEGDA con-
centration influences the mechanical properties [154, 155]. However, for completeness of
this model and in order to ensure the same relationship is observed, this microfluidic sys-
tem is the same as that witnessed in the macro-scale experiments. The following results
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show that with increasing concentrations of PEGDA there is a reduced deflection (figure 5.5
- coefficients for these graphs are presented in table 5.3), corresponding to literature.
Figure 5.5: Both graphs show the deflection in response to flow rate with different concen-
trations of PEGDA. A) is the deflection for 8 % PI and B) is the defection for 4 % PI.
103
Table 5.3: Coefficients used in power 2 fitting for figure 5.5
What is interesting about these results is that there is a larger range of deflection with 4 %
PI, this is probably because of the amount of cross-linking between the PI and PEGDA. It is
suggested in literature that with increased concentration of PEGDA and PI there is reduced
pore size[151]. The reduction in pore size will also increase the stiffness of the valve. Another
point to be made about all the above graphs is the trend is always the same, with a sharp
change in deflection at the lower flow rates and then plateauing off when the simple valve
is reaching it’s maximum deflection. The shape of the deflection is to be expected as when
the material approaches its maximum strain the valve will resist deflection irrelevant of the
addition of force, hence the plateau. It is the first linear section that is used for the calculation
of the Young’s Modulus as this is referred to as small deflection.
5.2.4 Young Modulus Results
As mentioned previously the deflection can be used to calculate the Young’s Modulus, E. The
next graph illustrates the region of the graph used, linear section, referred to as small deflec-
tion, u. Tunable stiffness of the valves is a desirable quality within this model as the stiffness
of valves in vivo increases with age [29]. It has not yet been thoroughly investigated how
valve stiffness and DVT could be linked, however with this model it is possible to determine
how the flexibility of valves influences flow; an important parameter when understanding
thrombus formation. The higher E is the more stiff the material, which is represented in
graph 5.6.
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Figure 5.6: The above figure represents data collected from 8% v/v PI A) shows a typical graph
of deflection against volumetric flow rate with B) highlighting the linear region, small deflec-
tion region used for the calculation of E shown in graph C). The green data point represents
the maximum E for PEGDA 575
Note that there is a linear extrapolation (light blue dashed line) to 100% (v/v) PEGDA
giving the maximum reading of 142 kPa which is the maximum Young’s modulus for PEGDA




Where R is the ideal gas constant, T is the temperature, ρ is the density and Mw is the molec-
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ular weight of 575 g/mol. This result (figure 5.6) suggests that optimum amount of PI is 8 %
to obtain maximum amount of cross linking between the polymer chains and would make
sense according to the deflection data seen in figure 5.5. To further investigate whether the
trend is true across concentrations of PEGDA and PI, table 5.4 highlights and re-iterates that
what has already been seen in literature [122]. Table 5.4 highlights the general increase in E
depending on concentration of PEGDA and PI, represented by the colours green (low) - red
(high). The standard error is also presented within this table. This indicates the ability to
tune valve stiffness by varying concentration of PEGDA and PI as exposure time is relatively
unreliable due to the denaturing of the PI over time. For these valves the lowest possible
exposure time was used in order to ensure reproducibility of the material properties.
Table 5.4: Table displaying E for various concentrations of PI and PEGDA. The varying colour
of the E column symbolises maximum E (red) and minimum E (green)
The stiffness of valves could be a key parameter for developing DVT and for this reason
it would be important to be able to quantify this in situ by ultra sound images. As is, this
model uses straight valves to characterise E, however this could be developed numerically to
take into account the curvature of the valve and would be something to consider for future
work. It is also possible to visualise flow using ultra sound doppler, flow in the veins will be
influenced by the skeletal muscles pumping blood as well as the efficiency of the valves to
prevent back flow. Therefore characterisation of the flow patterns around valves according
to the stiffness of the valves was carried out.
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5.3 Flow Patterns Around the Valves
The efficiency of a valve can be depicted by its ability to empty the stagnant region behind the
valve as well as close sufficiently to prevent back flow [156, 157]. Parameters affecting valve
efficiency would be geometry and material properties, e.g. stiffness. The valves within veins
are often referred to as leaflet valves, as they open like a leaflet towards the wall of the vessel
[158]. For this reason, to better mimic the in vivo conditions, a leaflet valve is fabricated
as mentioned in the materials and method chapter (sections 2.1.3 and 2.2.1). First of all,
it should be noted that the change in geometry meant that there was a difference in flow
around the valves (see figure 5.7). It can be seen that there is a much larger stagnant region
behind the leaflet valve, which is more representative to the in vivo case. Flow between the
valves is greater than that before, after and behind the valve, therefore multiple fps need to
be used to capture accurate GPV, similarly to what was seen in the stenosis model, this can
be seen from figure 5.7 and figure A.2, 60 µL/min (Re= 5). A higher fps is needed to record the
flow through the centre of the valve in comparison to a lower fps for the rest of the device.
Also to double check the stagnant region behind the valve slower fps were used to establish
whether or not the valve pocket was stagnant (figure A.2).
107
Figure 5.7: Velocity profile maps showing the difference in flow fields around the valves. No
masking was used, yet valves are still visible as no flow regions. Straight valve scale bar = 150
µm (top three images) and the leaflet valve scale bar = 75 µm (bottom three images). Re = 2,
3, 5 respectively.
At higher flow rates vortices occur at the valve tips and the geometry of the stagnant
region behind leaflet valve is considerably bigger compared to the simple geometry. Using
GPV it was possible to obtain detailed flow profiles. Venous flow is highly variable hence a
range of flow rates (1-900 µL/min) and elasticity of valves (see table 5.1) have been explored.
It was already known that with increased velocity the valve becomes more open, how-
ever using GPV it also revealed complex flow patterns occurring around the valves at higher
flow rates. Vortices occurred at the valve tips. It can be seen in figure 5.8 that as Re number
increases so does the size of the vortex. It is further demonstrated in figure 5.9 the linear rela-
tionship between Re and vortex area. It is evident that re-circulation zones initiate thrombus
formation and the greater the re-circulation zone, the larger the thrombus [159].
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Figure 5.8: A velocity map and streamlines highlighting how as Re increases the size of the
vortex also increases. The valve properties are 2 % w/v [PI] and 40 % w/v [PEGDA]).
Not only did the vortex increase in size, the tangent velocity also increased. PIVlab uses
Kutta-Joukowski theorem to calculate the recirculation of flow [125]. The circulation has the
units m2/s and is measured by integrating vorticity over the area of the centre of the vortex
[125]. The integrals are then calculated for a series of circles. Then by taking the maximum
value for the tangent velocity for the largest ’circle’ (outer most loop in the vortex), it can be
plotted in multiple ways, as function of deflection (figure 5.11) as well as flow rate (figure5.9).
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Figure 5.9: A representation of how vortex area increases with Re. Points are natural log (ln)
of both Vortex area and Re number. R2 = 0.99. f (x) =−12.61∗x−2.45 +10.95.
As to be expected as vortex area increases so does the tangent velocity, which in turn is
also linked to Re number. Even though it is shown that a vortex occurs behind the valve when
it opens and closes, flow patterns themselves have been relatively disregarded when it comes
to their influence of thrombus formation in veins. Yet as mentioned previously, recirculation
is important for platelet activation and shown with in figure 5.10 is the influence of Re on the
recirculation both in size and velocity. It should be noted this is not ignored in arterial and
cardiac investigations.
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Figure 5.10: Following on from graph 5.9 this plot adds a third dimension to the data indicat-
ing the relationship between Re, vortex area and the tangent velocity is linear.
To mimic a ‘healthy’ vein, the most flexible valve (E = 22.2±7 kPa) was used. This valve
opens to its maximum extent at the highest flow rate emptying the stagnant pocket behind
the valve. On the other hand, with a stiffer valve, an increased stagnant region and, conse-
quently, a higher residence time of fluid behind the valve is detected. This is representative
of elderly people where the valve tissue becomes less flexible due to an increase of fibrotic
tissue [160]. The increased stiffness also results in larger vortex occurring at the tip of the
valve (figure 5.11).
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Figure 5.11: A graph to present how the amount of deflection influences the size of the vortex
at different velocities.
It was discovered that when the velocity was lower than 0.024 m/s a vortex does not occur.
This is a result of the fact that the velocity between the stagnant and flow region is not great
enough for the vortex to occur even if the deflection is as great (if not greater) than the faster
velocities [161]. This could be emulating thrombus formation in vivo and therefore proposes
an alternative theory for how thrombus initiation occurs within venous conditions. It may
not be due to the stagnant region behind the valve encouraging thrombus formation and it
could actually be the presence of a vortex encouraging cell-cell interactions, e.g. collisions.
The larger the vortex, the more recirculation, the greater possibility that particle-particle col-
lisions will occur, and thus increasing the likely hood of an aggregate to form at the tip. It
should be noted that under laminar conditions, it has not been reported that the PS parti-
cles will stick the PEGDA. To emphasise this it is possible to look at the chemical structures
of both the PS particles and the PEGDA molecules (5.12).
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Figure 5.12: A schematic of the PS particle along with the PEGDA molecule.
It can be seen from the above figure 5.12 that the PS particle has carboxy groups on the
surface, this will inherently give the PS particle a slightly negative charge. As for PEGDA, the
molecule has also a slightly negative charge with the presence of the oxygen groups branch-
ing out of the molecule. As both PEGDA and PS particles are negative, this means that they
do not exhibit attractive forces between them. Throughout all of the continuous flow exper-
iments it became apparent that the 200 nm PS particles accumulated on the valve tips. In
order to investigate this further, pulsed flow conditions were used with larger PS particles
(3-10 µm to represent platelets and red blood cells respectively). The vortex was still present
during the forward flow of the particle suspension within the pulsed flow conditions.
5.3.1 Particle Accumulation
As mentioned at the beginning of this chapter two flow conditions were investigated. Venous
flow is not continuous; the blood is pumped back to the heart by muscle contractions and
the valves prevent back flow [162]. These conditions were replicated using the pressure con-
troller to create a pulsed flow. The closing of the valve causes back flow to occur, this change
in flow causes a recirculation in the valve pockets. This has been hypothesised and proved
using in silco models [4]. However, upon opening a vortex occurs at the valve tip, the same
as what was seen previously in the continuous flow experiments. This is believed to be the
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first experimental result showing this phenomenon at the tip of the valves therefore more
investigations are carried out.
Flow and valve stiffness were altered to investigate their influence of flow patterns. Con-
sequently these flow patterns caused the aggregation of 200 nm particles on the valve tips,
figure 5.13.
Figure 5.13: A bright field microscopy image of the 200 nm particle accumulation on the
valve tips.
To better understand this phenomenon and to represent in vivo conditions, larger parti-
cles (3-10 µm) were used to portray platelets and red blood cells respectively. It can be seen
from figure 5.14 the significant positive correlation of valve stiffness and particle accumula-
tion for both particle sizes. According to previous results it suggested that with stiffer valves
there was a larger vortex, this would also coincide with the hypothesis that greater recir-
culation regions also increases particle-particle interaction. In this case particle-boundary
interaction. It could be an explanation as to why developing DVT increases with age, as with
recent findings it has also been suggested that valves get stiffer with age [29]. Therefore, it
would be appropriate to propose that this model is a beneficial insight into the mechanisms
behind DVT, one that has not yet been investigated in depth.
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Figure 5.14: A histogram plot showing how the stiffness of the valve encourages particle ac-
cumulation on the valve tips. T = time (min).
It should be noted that in our system we can not account for the anti-thrombotic pro-
teins that line the leaflet valves preventing the accumulation of platelets. However, it has
been recognised that the valve stiffness increases with old age (as mentioned previously).
This could suggest the pathological physiology that presents itself with old age could also
reduce the secretion of anti-thrombotic proteins on the valve increasing the likelihood of
thrombus formation. In this study it is evident that particles accumulated quicker on stiffer
valves suggesting that the vortex is the cause for particle build up on the valve tips. This is
potentially the first experiment of its kind observing a localised particle build up on flexible
structures within a microfluidic channel. However, it is noted and understood that spheri-
cal particles suspended in water are not the most perfect representation of blood cells and
blood, the point of these experiments is to simply prove that this phenomenon exists and
should not be dismissed when trying to understand blood flow within veins.
In industry it is known that particles ’fall out of suspension’ due to accelerated shears
[163]. This could also be occurring in vivo as this phenomenon also occurs for various
shaped particles [163]. The event of particles coming out of suspension is well known within
industry and is understood across huge scales. Generally it causes sedimentation and ag-
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gregation of particles/polymers within the suspension on an industrial scale and is therefore
well understood for determining optimum mixing speeds and fluid conditions. In vivo. The
valves could be causing a high enough shear rate to instigate the aggregation of platelets
or pro-thrombotic proteins. For this reason further investigation needs to be carried out to
understand if this occurrence is happening in vivo and can be replicated using this in vitro
model.
It does not seem logical to assume that the valve in vivo stiffness will increase at the same
rate. An idea only found to be suggested once in literature by Karasu et al. [29]. Conse-
quently, valves were then fabricated with asymmetric stiffness. Presented here in figure 5.15
is that particles accumulate behind the more flexible valve as theorised by clinicians. How-
ever, this is opposite to what was seen in the symmetrical valves. The majority of the particle
accumulation occurred behind the more flexible valve (figure 5.15 bottom image panel, left
hand side valve). This indicates that the particle build up in this case is due to the back flow
on the closing of the valve as opposed to the presence of a vortex on the opening of the valve.
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Figure 5.15: Bright field images showing the particle build up over time in symmetrical (top)
and asymmetrical (bottom) stiffness of valves. The concentration of 10 µm particles is 1 %
w/v. The symmetrical valve has the composition of 4 % v/v PI and 50 % vv PEGDA. The
asymmetric valve is the same composition as the symmetrical valves, however the exposure
time for the left (most flexible) and right (stiff) are different.
.
In the comparison between the symmetrical and asymmetrical valves seen in figure 5.14
the asymmetrical valve has a greater accumulation of particles. This is possibly a result of
back flow forcing the particles onto the back of the valve. This could is a strong indication
as to what could be happening to cause DVT. Although, all biological influences have been
stripped from this model, the proof that valve stiffness and flow has a strong influence on
particle accumulation should be sufficient proof that these parameters should not be ig-
nored when developing the understanding the mechanisms behind DVT.
5.4 3D Printed Valve Geometry
In order to extend this model, 3D printed geometries were used with rigid valves in push the
limitations of the microfluidic set up into higher Re numbers. The experimental parameters
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reached their limit with the proposed flow detection technique. This was overcome with
various simulations which will be discussed later ensuring the Re number of the in vivo case
was reached and analysed. The model was progressed further into a more realistic in vivo
situation, 3D printing was used to achieve higher Re numbers. Similar to the stenosis 3D
printed device there where complications with the fabrication and assembly of the device.
The square cross-section was maintained with the initial geometry (4x4 mm) and valves were
cut out of the resin mould.
The first issue was found when the PDMS was poured over the mould, and left to cure. In
the peeling away process, the valves were too intricate and did not come out of the mould.
This was overcome simply by 3D printing valves as seen in the Material and Methods section
2.2.1. This meant that the valves were confined to being static, however because the valves
are implanted into the PDMS, this means there is no leakage around the valves ensuring
there is no flow in the z-direction (coming over/under the valve).
Even though the valves did not come out into the PDMS device, the experiment was run
anyway to ensure that the 4 mm depth was suitable for GPV. Unfortunately it was found that
there was too much interference. This then initiated the fabrication of a W = 2x4mm device.
Narrowing the device reduces the signal to noise ratio, it also makes it more comparative
to the microfluidic devices which also have a more rectangular geometry as opposed to a
square geometry. The addition of valves was also slightly altered. Instead of them being
subtracted from the PDMS, they were 3D printed. This meant that they could be stuck to the
channel walls, and embedded slightly into the PDMS to prevent leakage, sanded down to the
exact channel height (2 mm) and stuck to a glass slide using the epoxy resin. Although not
ideal it enabled fabrication of a fully transparent, functioning milli-fluidic chip.
The fabrication and experimental set up was finalised it was possible to explore how
higher Re number’s influence flow around the valves. It was found that the vortex contin-
ues to increase in size as expected in laminar conditions (figure 5.16).
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Figure 5.16: A schematic representation of the 3D printed valve device highlighting the re-
gion of interest where the results at the bottom of the figure were obtained.
The acquisition of these results was complex, air bubbles were a huge problem and inter-
fered with GPV capture resulting in an unreliable flow regime map being plotted. To remove
bubbles a pressure was applied to the outlet adding a counter pressure forcing the air out of
the channel. Data collection could continue, but as seen above in figure 5.16, this was only
a short term fix. A longer term fix was to clamp either side of the channel to prevent leakage
from the PDMS/glass interface, which was not adhered via corona discharge.
5.5 Simulation
Valve length is a key parameter for influencing the flow conditions. Not only does it affect the
deflection of the valve induced by various flow conditions it will also effect the size of the vor-
tex at the valve tip. The fact that particle accumulation occurs predominantly at the valve tip
suggests the vortex could play a fundamental role. The vortex at the tip of the valve could be
trapping particles encouraging an affinity between particles and the valve surface. It should
also be mentioned the valves in veins do not close fully meaning that FEM modelling would
be an appropriate tool due to the mesh being present meaning that the two solid bodies
cannot come together to meet in the middle due to the fluid body being between them.
Originally, the geometry used as the photo-mask was also used as the geometry for the
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valves in the simulations. The inlet boundary conditions were altered to have an increasing
velocity from 0.01-0.75 m/s while everything else remained constant. The walls and valve
boundaries were set to have no slip boundary conditions and the outlet boundary conditions
had atmospheric parameters applied. The mesh was refined at the tip of the valve to ensure
the CFD model was fine enough to pick up the vortex, this was done by adding points which
had a 0.1 refinement factor on the global fine-ness of the mesh. It can be seen from the long
valve that the vortex occurs just behind the valve tip. This is different to the experimental
results. However in this simulation the valves have no elastic property and the tips are a lot
sharper than used in the experiments, which could influence the simulation results. It was
seen that at lower velocities there was no vortex occurring and the velocity represented in
figure 5.17 indicates that the maximum velocity magnitude is 1.376 m/s which is very high
and would not be physically possible in the microfluidic devices. It suggests that the laminar
flow regime does not change and the vortex does still occur. This is further indicated by
figure 5.18
Figure 5.17: A zoomed in velocity magnitude map of featuring the long valves.
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Figure 5.18: The velocity map above the graphs indicate the coordinates on position y in
which Plot A) shows the parabolic flow before the valve increasing as the velocity increases.
This is also highlighted in plot B), which is the velocity after the valves, it indicates that there
is a vortex at velocities 4 and 5 highlighted by the black dashed circles. The Purple line in
both plots is the parabolic flow visualised in the previous figure 5.17.
A shorter valve was also investigated with the same boundary conditions 5.19. And al-
though it appears that the vortex increases in size along with the increased Re number, the
shape of the vortex also changes. It appears to go from emptying behind the valves at at
the experimental Re number to recirculating at the valve tips at the higher Re number. This
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occurs at 0.5 m/s, Re = 61 and increases in size down the channel as seen in experiments.
Figure 5.19: Velocity magnitude map of the simulation data showing the presence of a vortex
and that it increases with Re number.
The reason the simulations cannot be used to validate the experimental results could be
due to lack of 3D flow, however, this is unlikely due to the laminar flow profiles. To ensure this
is not the case a 3D simulation was carried out, the results were the same. This in mind there
must be something wrong with the mesh or the simulation itself. As mentioned previously,
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the Elmer results were compared to results obtained in COMSOL, meaning the simulation
is unlikely to be wrong. Narrowing it down to the mesh refinement. Another possibility
is the shape of the mesh, Gmsh uses triangle/tetrahedral cells for 2D and 3D simulations
respectively. Tetrahedral mesh’s appear to be most commonly used for fluid flow and elastic
structures, demonstrating perhaps the mesh refinement is not optimum for this simulation.
Further investigation into optimising the mesh was carried out with greater localised re-
finement around the valves in order to be a high enough resolution to compute the vortex.
Unfortunately results were the same as witnessed earlier, indicating perhaps a geometrical
issue. The valves in the experiments have a slightly rounded tip which could be strongly in-
fluencing the flow. In order to prove this the valve geometry was slightly changed to be given
a ’curved’ tip (figure 5.20). Again, this did not seem to aid in the validation of the experi-
mental results with replicating and advancing the valve model to more in vivo conditions.
Obviously in the experiments there is a force acting against the fluid because the valves are
flexible. Elmer is a multiphysics software meaning it is possible to add deformation of the
valve as well as the Navier-Stokes equation. This also did not replicate experimental results.
Figure 5.20: A zoomed in velocity magnitude map of featuring the long curved tipped valves.
Simulations do enforce ideal conditions that are not achievable within experiments. For
example, if 0.75 m/s was pumped into the microfluidic device the inlet and outlet tubing
would detach from the microfluidic device because there would be too much pressure. The
aim of the simulations was to strengthen the experimental results as well as extrapolating
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the micro- and milli- fluidic results to a more realistic in vivo condition:
• Increasing Re number
• Using GPV means that at high Re number the detection becomes unreliable in the 3D
printed devices[100]
The overcoming of these limitations was carried out, however the results were not as ex-
pected. The similarities lie within the fact the: flow is laminar, the velocity increases through
the valve as expected and the velocities are roughly the same as seem in experimental re-
sults. Unfortunately the main, crucial difference is the position of the vortex. This could be
due to more time required for the optimisation of the mesh or that 3D simulations are def-
initely needed in order to get a true representation of the experimental results. As in FEM
simulations the mesh optimisation is essential for getting accurate results. In this thesis, the
mesh still needs refinement around the vortex area in order to get more accurate results.
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CHAPTER 6
CONCLUSION AND FUTURE WORK
6.1 Conclusion
With in this thesis various models have been developed answering complex questions. In
this section chapters 3-5 will be concluded followed by possible future development of each
model. Three models have been developed to investigate different physical parameters which
can be useful for understanding DVT. The first two models focussed on geometry and the in-
fluence on velocity through the entire device. The final model focussed on the presence of
valve and observed the influence on flow patterns and particle accumulation.
6.1.1 Stenosis Model
The design and fabrication of a stenosis model to mimic the geometrical aspects of the in
vivo murine model was accomplished. It highlighted that although the biological approach
is useful for development of anti thrombotic pharmaceuticals has major limitations when it
came to understanding the physics behind thrombus formation. There is not a 100% throm-
bus formation in the stenosis model in vivo, the reason for this was unclear [44]. It became
clear within the literature review that little was researched in terms of geometrical influ-
ence of thrombus formation. For this reason a number of geometries was investigated. Al-
though already known that flow within in a mouse is very unlikely to the turbulent, the in
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vitro model was designed to prove just that. It became clear that the thrombus formation
occurring within the murine model were probably not due to recirculation before the steno-
sis and is more likely to be due to an accumulation of blood cells at the stenosis causing a
thrombus to materialise.
Two geometries where investigated including a square cross sectional device and a 1/2
cylindrical device. The square cross sectional microfluidic devices showed no change in lam-
inar flow regime across a wide range of geometries and flow rates. In this section the GPV
set up was established and optimised for micrometer and millimeter scales. Even with cur-
vature the flow was not altered, the parabolic flow was measured in the lateral and medial
direction. Unfortunately the fabrication of the full cylinder required a more complex adhe-
sion approach. For this reason the devices following this initial simple model were all square
cross sectional devices due to ease of fabrication and reproducibility.
The presence of side branches was also investigated due to reports in literature indicating
that there was a recirculation happening before the stenosis preventing a thrombus forming.
However, these studies indicate, that with whole blood the flow within the microfluidic di-
mensions are going to remain laminar with the additional flow coming from the side branch
regardless to it being greater or lower than the flow within the main channel (representing
the IVC within a mouse). This being said, it would seem that the majority of the murine
models ignore the rest of the mouse and the fact that a bypass could be occurring. And, al-
though studies are correct in saying that a presence of the side branch influences thrombus
formation and growth the reasons behind this are not understood. Without this preliminary
work in the development of the stenosis model the following models would have not been
possible.
6.1.2 Bypass Model
The main limitation with this model is the fact that it is a simple geometry and the cardio-
vascular system is a complex network of various sized vessels which will transport blood
around the stenosis. However, it is a simple, smart way to present the possibility of a bypass
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which will encourage/discourage thrombus formation depending on its location and width
of side branch. It was found that position A (1600 µm away from the stenosis) did not cause a
bypass, and therefore has similar results to the stenosis model in that a thrombus could pos-
sibly form due to a ’bottle neck’ effect increasing cell-to-cell interactions. As for positions
B (600 µm) and C (300 µm) a bypass still occurs, and a stagnant region before the stenosis
and after the side branch occurs. It was evident that it was dependent on multiple factors,
including: width of side branch, flow rate applied to main channel and side branch as well
as stenosis.
It was determined that all parameters drastically change the velocity through the chan-
nels depending on the flow rates in the side branch and main channel. The difference in flow
rates through the side branch and main channel changes the pressure of the device. There
will be a pressure drop when the velocity in the side branch is lower than the pressure in the
main channel. There will also be a difference in pressure when the main channel has a lower
pressure than the side branch. The latter is more likely to occur in vivo. These studies indi-
cate that under different flow conditions and different geometries induce stagnant regions at
different parts throughout the device. Three regions predominantly have stagnant regions:
main channel after the side branch, side branch and bypass. A full bypasses occurred when
the flow rate in the side branch was lower than in the flow rate in the main channel indepen-
dent of position of side branch (B or C) and side branch width. However, this was also due
to having a 80 % stenosis. If the stenosis was smaller a bypass is less likely to happen. Thus
concluding the main contribution to a bypass is stenosis and flow rate in the side branch.
A restriction is induced in vivo, when investigating DVT. With an increased stenosis there is
likely to be a stagnant region between the side branch and the stenosis, which is more likely




An advancement from the simplistic stenosis model was carried out with the development
of fundamental understanding of fluid structure interactions. In short, the development of
a valve model has been achieved. The fabrication and characterisation of flexible valves has
been carried out in situ developing a more representative in vitro model. It was possible
to tune the flexibility of the valves by altering concentration of PEGDA, PI and altering the
exposure time. After the characterisation of the valves using the straight geometry the move-
ment on to a more physiologically correct geometry was created. This leaflet valve geometry
allowed for the observation of complex flow patterns at various flow rates. It was evident
that with an increased flow rate encouraged the formation of a vortex which gained in size
as the velocity increased. The flexibility of the valve was important here, as with the more
flexible valves meant that there was a smaller/if any vortex formation. This was a result of
the deformation of the valve being increased and reducing the gap between the valve tip and
the channel wall. The stiffness of the valve also affects particle accumulation. The stiffer the
valve the more particles accumulate on the valve tips. It is suggested that the vortex is what
promotes the localised aggregation of particles. Furthermore, when the valves are asymmet-
rical the accumulation of particles occurs behind the valves. It is predicted that this happens
in vivo. The development of this model has raised more crucial questions in order to un-
derstand the physical mechanisms behind venous thrombosis. The use of bio-compatible
materials: PDMS and PEGDA means that the device is ready for the integration of biology,
both materials were picked due to their biocompatibility as mentioned previously. Further
development of this model would better integrate biology. In order to do this firstly endothe-
lial cells would be added and the use of the PEGDA hydrogel would enable the development
of the extra cellular matrix due to its porous network.
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6.1.4 Simulations
The simulations within this thesis were not an advancement of venous flow modelling. There
are many elegant in silco models of the complex venous system. The purpose of simulations
was to validate the experimental model, with the aim to advance into more in vitro flow
regimes. This was carried out. It was shown that the simulation data matched that of the ex-
perimental data in most cases and that the few times where it did not replicate experimental
conditions there was an obvious error with the simulation and can be considered inaccurate.
All results, positive and negative were presented throughout to explicitly indicate where is-
sues were arising. In particular the 3D simulation in section 3.1.6 the results did not seem
reliable. Within the whole stenosis model simulation results, although not a complicated ge-
ometry or CFD simulation was certainly successful in terms of learning 3 different software
and understanding the process from designing the mesh through to interpretation of the
data. A process not learnt in depth when using more conventional software such as Comsol
to carry out these simulations which is a more ’black-box’ approach. These skills learnt in
chapter 3 were used more extensively in chapter 5 section 5.5, where they were advanced
further to have moving solid structures within the simulation.
Finally, it should be stated that these simulations where by no means the state of the
art, however they served a purpose and should be advanced further. Although, it would
be accurate to say that mesh free simulations are more accurate when investigating fluid
structure interactions in biology, giving greater control and in some retrospect, increased
resolution of results.
6.2 Limitations and Future Work
Starting with the stenosis model, more blood work experiments needs to be carried out to in-
vestigate more thoroughly where platelets adhere to the channel depending on size of steno-
sis. This should also be replicated in the bypass design experiments. As the results could be
very different with the implementation of a stagnant region before the stenosis. Another in-
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teresting phenomenon not covered in this thesis would be to look at cell-cell interactions.
This could involve the addition of endothelial cells to the channel walls and look at physical
parameters. This could be implemented by using the different geometric designs suggested
in this thesis alongside various flow rates to identify localised adherence and accumulation
of platelets (or red blood cells) . It is not to my knowledge that this has been explored. How-
ever, I believe it would be an elegant, extensive way to investigate how different flow patterns
induce thrombus formation within the murine model.
Throughout the majority of experimental work there has been some degree of accumu-
lation of particles at various points through the microfluidic channel. Whether it be in the
centre of the stenosis, to the tips of the valve. More investigations into the theory behind
what is happening is paramount to understand how thrombus formation within the veins
occurs due to the multitude of flow conditions which can occur.
6.2.1 Stenosis Model
The development of this model was carried out throughout training of GPV capture and the-
oretical understanding. It was useful at determining optimum microscope settings for GPV
capture, as well as the development of skills: such as microfabrication, CFD and 3D printing
techniques alike. To progress this in particular model the integration of biology would be
useful. Although preliminary data has been collected, further investigation should be car-
ried out. Using different viscosity of fluids, non-Newtonian fluids, alter the flexibility of the
microfluidic channel etc.
Possible uses for this device could be the understanding of ageing on the coagulation of
blood as well as other fundamental blood properties such as haematocrit number and rhe-
ology. Firstly, this can be investigated using blood analogues, followed by different blood
samples, healthy and diseased. It could also be used to understand the influences of obesity
and chemotherapy on thrombus formation within the deep veins. Using the same geometry
and similar experimental set up it will be possible to use different blood samples and de-
termine what causes more platelets to aggregate. It will be possible to investigate particular
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biomarkers which may cause the increased aggregation. An area of interest was the anomaly
result collected when using whole blood. The majority of blood samples was collected from
<50 years of age except one. The one sample that was collected from a volunteer >50 years
reproduced the results witnessed in the murine models. This could either be coincidence or
a factor of age as mentioned in the introduction, the likelihood of developing DVT increases
with age. Therefore further investigation into this factor would be interesting and useful for
understanding the physical mechanisms behind DVT. It could also be possible to line the
device with cells and look into biomarkers using fluorescent microscopy. Possible markers
could be pro-thrombotic proteins: fibrin/thrombin/von Willebrand factor. Another inter-
esting parameter not investigated within this study is the influence of the elasticity of the
channel wall. This would be an important factor when trying to understand the biological
responses in relation to mechanistic physiology (e.g. increased fibrotic blood vessel tissue
would increase the rigidity of the vessel). This is just a couple of ways in which the stenosis
model can be expanded and although not investigated in this thesis are parameters that are
in need of investigating to truly understand the physical parameters of DVT.
6.2.2 Bypass Model
The bypass model was advancing into a more complex design, involving pumps to constrict
the channel from both sides. Unfortunately the PDMS was too stiff to apply a sufficient
enough stenosis to the main channel to enforce a bypass. To over come this issue PDMS
can be made more flexible by altering the curing agent to PDMS ratio. This would enhance
the flexibility thus allowing for more refined control over the stenosis over time. The bypass
model, as with the other models, uses water and particle suspensions which is not represen-
tative of whole blood. This can be over come by making blood mimicking fluids. The use of
more viscous fluid would have different parameters in which induce a bypass. The bypass
could also be made more complicated in replication of the complex network of blood vessels
in vivo.
To push this study further it would have been useful to calculate the pressure drop through-
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out the channel. This can be linked to the velocity through the IVC and a side branch in vivo
it would be an elegant way to begin to understand blood flow through the venous system.
Obviously this would not be representative of a human/large mammal case due to the pres-
ence of valve but the integration of valves and the bypass design could be a possible solution.
This would not negate the whole study, as flexibility of the valve will influence the resistance
of fluid being able to flow through the channel and will create a restriction if the valves are
stiff enough.
It does need to be determined what is the actual cause of the thrombus before the steno-
sis and although this model has highlighted that a bypass can happen, it has also demon-
strated that there are multiple stagnant regions in which a thrombus can occur as well as the
accumulation of particles on the bifurcations. This raises the question is the thrombus form-
ing elsewhere and getting stuck at the stenosis or is it actually forming before the stenosis?
6.2.3 Valve Model
The development of this model has given rise to many more questions and paths to aid in the
development of understanding physical mechanisms behind DVT. From a critical perspec-
tive the model lacks biological input throughout, however thorough characterisation has
been carried out providing an ideal platform to further investigate the link between physical
parameter and biological responses in DVT (and potentially other venous diseases). The first
obvious advancement would be to flow blood through the valves and determine whether or
not they behave similarly to the simple fluid; with the localised particle accumulation at the
valve tips. This can be carried out in stages, by using other transparent non-Newtonian flu-
ids to mimic in order to mimic blood before carrying out actual blood experiments. Further
down the line, detailed routes such as identifying how haematocrit influences flow patterns
and thrombus formation would be very interesting.
Another advancement could be to develop the device itself into more of a vein-on-a-chip
with the addition of endothelial cells. This would require extensive characterisation in order
to seed the cells into the device and proliferate into a homogenous monolayer across the
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surface of the device. In order to aid with the adhesion of endothelial cells various proteins
can also be loaded to coat the device prior to cell seeding. Proteins such as collagen and
fibrinogen have been used previously. Once the cells are seeded into the device it would en-
able the investigation of cell-cell interaction. Although, personally, the investigation of dif-
ferent morphologies of cells throughout the device would be the first parameter to look at.
The morphology of the cell may influence secretion of pro-thrombotic or non-thrombotic
proteins which will itself influence platelet aggregation. The morphology of the cells may
change depending on the stiffness of the valve making it a good starting point into trying
to understand why valves are important to thrombus formation. Finally it has already been
proven that valve stiffness causes different flow patterns around the valve, it would be inter-
esting to see how these flow patterns also influence the endothelial cells.
This will truely become a vein-on-a-chip device to look at various venous diseases under-
standing fundamental mechanisms behind secretion of specific anti-thrombotic and throm-
botic proteins as bio-markers.
6.2.4 Simulations
Although FE simulations are not optimal for carrying out such complex simulations on fluid-
structure interactions it does have the added advantage that localised mesh refinement can
increase stiffness along the valve. This would be interesting to investigate how localised stiff-
ness can influence the flow through the valve. Another more simple development would be
to replicate the experimental results by having the valves acting as two separate physical
groups in order to apply asymmetrical stiffness to the valves.
Further development of mesh free simulation software should be carried out to make
it more accessible to other disciplines, like FE simulation software. As it currently stands,
mesh free simulations are restricted to those who have the suitable expertise and are not yet
accessible to the wider academic population. It provides a very powerful tool for looking into
biological mechanism, especially for the cases of DVT where there is high variability arising
from a physiological and environmental circumstances.
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The following is an example of the .sif code used with Elmer finite element multi-physics
software. Each section is spaced and commented in green.
Loads the mesh into the Elmer software, creates space to put results. It is important to keep
mesh, geometry and elmer .sif document in the same folder
Header
CHECK KEYWORDS Warn




Sets the controls. The simulation is steady state as it will not change over time. The sec-
tion also the name of the results file which is set to .vtu to analyse in paraview. It also selects
the .sif file in which to compute the results. coordinate mapping is set 1, 2, 3 for x, y, z this
can be altered depending on the orientation of the geometry when inputted into Elmer. The
other parameters are default
Simulation
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Max Output Level = 5
Coordinate System = Cartesian
Coordinate Mapping(3) = 1 2 3
Simulation Type = Steady state
Steady State Max Iterations = 1
Output Intervals = 1
Timestepping Method = BDF
BDF Order = 1
Solver Input File = case.sif
Post File = case.vtu
End
Applies all the constants
Constants
Gravity(4) = 0 -1 0 9.82
Stefan Boltzmann = 5.67e−08
Permittivity of Vacuum = 8.8542e−12
Boltzmann Constant = 1.3807e−23
Unit Charge = 1.602e−19
End
Target body is the physical groups determined in gmsh, and the rest states the number of
equations used/surfaces and materials used in this particular simulation
Body 1
Target Bodies(1) = 4





Use of solvers within the Elmer package. Options to add bubbes, destabilisation of the
fluid, lumped mass (useful for emulating a thromus). It is possible to alter number iterations
Solver 1
Equation = Navier-Stokes
Procedure = "FlowSolve" "FlowSolver"
Variable = Flow Solution[Velocity:2 Pressure:1]
Exec Solver = Always
Stabilize = True
Bubbles = False
Lumped Mass Matrix = False
Optimize Bandwidth = True
Steady State Convergence Tolerance = 1.0e−5
Nonlinear System Convergence Tolerance = 1.0e−7
Nonlinear System Max Iterations = 200
Nonlinear System Newton After Iterations = 30
Nonlinear System Newton After Tolerance = 1.0e−3
Nonlinear System Relaxation Factor = 1
Linear System Solver = Iterative
Linear System Iterative Method = BiCGStab
Linear System Max Iterations = 5000
Linear System Convergence Tolerance = 1.0e−10
BiCGstabl polynomial degree = 2
Linear System Preconditioning = Diagonal
Linear System ILUT Tolerance = 1.0e−3
Linear System Abort Not Converged = False
Linear System Residual Output = 1
Linear System Precondition Recompute = 1
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End
Equation used in the solver
Equation 1
Name = "navier stoke"
Active Solvers(1) = 1
End
Starting with an ideal fluid is useful to test the simulation before adding the parameters






The boundary conditions can be labelled and physical parameters can be added here
Boundary Condition 1
Target Boundaries(1) = 1
Name = "Inlet"
Velocity 1 = 0.1
Velocity 2 = 0.0
End
Boundary Condition 2
Target Boundaries(1) = 2
Name = "Oultet"




Target Boundaries(1) = 3
Name = "Wall"
Noslip wall BC = True
End
A.2 Chapter 3: Stenosis Model
Reports were created using the COMSOL software including information about the mesh,
the equations used and the results. The folder is available upon request.
A.3 Chapter 4: Bypass Model
Comparison between the two positions B and C with the side branch width of 100 µm.
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Figure A.1: Comparison between the two positions B and C. Plots A and C show position B
side branch and main channel flow rates respectively and plot B and D show position C side
branch and main channel flow rates changing.
A.4 Chapter 5: Valve Model
The following figure A.2 is further evidence of the varied velocities through and around the
valves.
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Figure A.2: An example of the different velocities around the valve, indicating the stagnant
region behind the valve as well as the fast region through the centre.
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